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1 CHAPTER 1 
 
1.1 Introduction 
Since the ancient times philosophers and thinkers have been questioning the structure 
of material. The ancient Greeks elaborated the concept of “elements” as fundamental 
substances which gave origin to all forms of material. 
In particular, Aristotle identified 4 elements: earth, air, fire and water, which 
according to his studies, if combined in the right proportions, could have originated 
all other substances. 
At the same time Democritus from Abdera theorized the existence of tiny and 
indivisible particles which form all the existing material; in this way the concept of 
atom (from the Greek gr. ἄτομος «indivisible») was introduced for the first time. 
Only in the XX century we have the scientific proof of the existence not only of the 
atom but of many atomic species, defined elements; their combination forms all the 
substances and so the material, too. 
Once the most common chemical elements were characterized, it was necessary to 
classify them by using a criterium which could join them in a well-ordered way. 
This criterium was acknowledged for the first time by the Russian chemist Dmitri 
Ivanovic Mendeleev who created the Periodic Table in 1865. 
In time the Periodic Table has been changed due to the finding of new elements; 
nowadays it is possible to differentiate several element groups. 
Referring to the biological organisms, we can differentiate some elements which are 
fundamental for life, so extremely abundant in the organisms (C, H, O, N, S...), others 
which are essential at low concentrations (Se, I, Co and so on...) and others totally 
extraneous to the living organisms, defined as xenobiotic, which are considered 
harmful and very toxic (i.e. lead and mercury). There is also another particular group 
of elements called rare earth elements (REEs), which are considered ideal candidates 
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for geo-referencing and traceability studies in food chemstry. 
 
1.1.1 Toxic metals and Rare Earth Elements (REEs) 
Metals are the toxic agents which have been known for a long time by  human beings. 
Differently from other toxic substances, they are neither created nor destroyed by 
man. 
Man's action (extraction and working for industrial purposes) has influenced the state 
of conservation of metals in nature, and has caused a diffusion and contamination of 
air, water, soil and food with harmful effects on our health as a consequence. 
Since the ancient times (see book Plutarch, Hippocrates 370 B.C. and so on...), the 
pathogen activity of some metals was known, as for example mercury and lead. 
Later, this definition has been diffused including elements such as cadmium, 
aluminum, arsenic …. 
The redistribution of metals in the environment takes place naturally through the 
biogeochemical cycles. The rain dissolves minerals and rocks by carrying them to 
waterways which extract and deposit materials from the lands where they flow. 
Finally, the water arrives at the sea where the metals can be precipitated as sediments 
or can be taken up to the atmosphere where they fall down again as rains, in order to 
be redistributed in other areas of the Planet (figure 1) (1). 
Finally, we have, through the biological cycles which include the incorporation in 
the food chain, the accumulation of these substances, first in the plants and then in 
the animals. 
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Figure 1: transport of trace elements in the environment (1). 
 
Moreover,  human activity has determined the formation of new compounds and a 
big increase in the world distribution of these elements. 
The metals come in contact with man through water, air, food and drugs. Some 
examples of how these elements are in relation one to each other can be the case of 
the disaster of Minamata and the case of the Itai-Itai disease. 
 
Minamata case in Japan 
The Minamata disease takes its name from the Japanese town of Minamata and it 
has been documented for the first time in May 1956 (2,3). 
In 1908 the Chisso Corporation (Chisso Co. Ltd) opened a chemical factory, in 
Minimata, for the production of fertilizers; later, it expanded and included the 
production of acetylene, acetaldehyde, acetic acid, vinyl chloride and octanol. The 
chemical plant became the most advanced center of Japan both before and after the 
Second World War. 
The chemical reaction to produce acetaldehyde requires the use of mercury sulfate 
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as catalyzer; it produces, as a residual by-product of the reaction, a small quantity of 
methylmercury (MeHg) (National Institute Minamata Disease) (4). 
This highly toxic compound was released through the wastewaters of the factory in 
the Minimata Bay, from the beginning of the production in 1932 until its interruption 
in 1968. 
The methylmercury accumulated first in the ichthyofauna and then through the food 
chain, among the inhabitants of the area who have a diet highly rich in fish and 
seafood coming from the Minamata Bay. 
The geographical distribution of Minamata disease3 cases is shown in figure 2. 
 
Figure 2: Map of Japan with Minamata Bay (3). 
 
Among those inhabitants, the following symptoms were observed: sensory 
alterations (similar to those caused by glues), ataxia, dysarthria, reduction of field of 
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view, hearing ailments and tremors (5). 
The exposition of the fetus to methylmercury, after the mother had eaten 
contaminated fish, caused much more serious consequences compared to those 
observed in the adults, because MeHg can cross the placenta and readily pass through 
the blood-brain barrier in pregnant women (6). 
Cases of brain paralysis, hypoplasia of neurons of the brain cortex, growth break off 
and destruction of neurons could be observed (7-9). 
This resulted in extreme fetal abnormalities and neurotoxicity (i.e., microcephaly, 
blindness, severe mental and physical developmental retardation) even among 
infants born from mothers with minimal symptoms (6). 
In this case, the syndrome took the name of “congenital Minamata disease” (10,11). 
The Minamata syndrome is also known as “laughing dead”, because the patient dies 
with a sort of smile on his face, due to the tetanus paralysis of the face (trismus). 
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An epidemic case of Itai-Itai 
Cai et al. (1995) found an epidemic form of “Itai-Itai disease” in the people of a 
group of villages situated on the banks of the Zhang River and the Fujang River in 
the Province of Jianxi in the south of  China (figure 3). 
They also analyzed the people who lived in the villages near the banks of the Youxian 
River, who did not show the same syndrome. 
As the etiology of the disease was known, they evaluated the concentration of 
cadmium in the urine, hair and nails of ill people (villages of Zhang and Fujiang) and 
of healthy people (villages near Youxian); they found a high concentration of the 
metal in the former ones and normal concentration in the latter. 
They looked for the presence of the metal in food and in the soils, eventually, they 
found the sources in two tungsten mines upstream of the two rivers, which 
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discharged pollutants in the waters destined to be used by farmers to irrigate 
agricultural fields including rice patties (12). 
 
      Figure 3: geographical map of South China (12) 
 
Regarding the toxic heavy metals, they are further discussed independently hereafter.  
 
1.1.1.1 Lead 
Among the most toxic elements, the most widespread is lead, in fact, its presence 
can be found almost in any biological system. It has no physiological function in the 
living organisms, neither plant nor animal, and for this reason, it is toxic if it 
surpasses a limited amount. However, the definition of this limit, for any organism, 
is a problem that has no easy solution.  
Children are the most affected by this metal because lead changes many functions 
linked to their development and, in addition, some systems of defense in children, 
such as the blood-brain barrier, are not completely formed and effective (13). 
The first people who extracted and used lead were the Egyptians, the Jews and the 
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Phoenicians (14). Thanks to its Physical-chemical characteristics, lead was widely 
used (i.e.to vitrify the porous surface of ceramics, to coin money etc), even though it 
was extremely dangerous for human health.  
The ancient Romans realized about the neurotoxic effects caused by lead poisoning, 
in fact the saying “mad as a painter” comes from the use of “Pompeii red”, which 
consisted in lead oxide (15). Another example of “lead poisoning” among the ancient 
Romans was caused by the use of a sweetener called sapa (lead acetate) which was 
obtained by cooking the grape must in lead containers (16). 
Lead poisoning was therefore known since the ancient times and although in the 
following centuries the documented cases in the literature are occasional, the 
pathology appears again in the documents of the XIX century, when in the period of 
industrialization, it reaches vast proportions. In 1920, the introduction of tetraethyl 
lead in fuels, caused serious damage to the public health, until it was banned in the 
1980s. However, the use of tetraethyl lead was so large that it caused a big diffusion 
in the atmosphere, as witnessed by a 200-fold increase of lead in the ice in Greenland 
(17). 
Lead, as an environmental pollutant, can come from several sources that can be 
worked or not; among those one can mention: industrial emissions (i.e. PM10), 
tetraethyl lead added to fuel (TEP) from 1923 to 1975, lead piping, kitchen tools, 
food boxes welded with lead, lead paints, mining, waste batteries, lead welding, 
pesticides which were used in the past in agriculture (arsenate) and contaminated 
food (18). 
Lead is most commonly absorbed through the respiratory system, gastrointestinal 
tract (gastroenteric)  and through transdermal means (19). 
The inhaled absorption has significantly decreased since the lead compounds in fuels 
have been replaced by adding benzene as an antiknock, even if a new problem was 
created since  benzene can cause leukemia. The gastroenteric absorption is not 
uniform in the exposed people: in particular, the affecting factors are age and diet 
(19). 
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Children, and all people who have a diet lacking in iron, calcium and zinc, absorb 
lead much more quickly and easily (20). Excretion takes place both by urine and by 
feces (21). 
After absorption, about 90% of the lead is deposited and accumulated in the bone 
tissue and in the hemopoietic mallow. In this last case in particular, it interferes with 
the synthesis of the heme group and of the hemoglobin in the erythroid precursors 
(22). When the bone is remodeled also lead and likewise calcium, is redistributed in 
the organism (23). 
Even from very low lead levels, we can notice some pathologic effects on different 
tissues, up to high levels showing acute intoxication. 
At low lead levels, a reduction of the intellectual quotient IQ (24), hearing deficiency 
and some developmental and behavioral disorders in children can be observed. 
As the concentration increases it is possible to note some alterations of the 
metabolism of vitamin D (22), variations in the enzymatic expression in the 
erythrocytes or in their precursors, anemia due to the underproduction of 
hemoglobin, headache, perception of metallic flavour in the mouth, lack of appetite, 
constipation, abdominal colic, tremors, kidney damage with excretion of  uric acid, 
neuropathy  and encephalopathy (25). 
In pregnant women, lead has a very hidden action because it is able to cross the 
placenta and spread in the fetal tissues (26). This can cause extremely serious 
malformations such as anencephaly, or spina bifida (18). 
In conclusion, it is better to remember that even with concentrations which are 
classified as nonpathological, lead can have important toxic effects if there are other 
toxic elements like for example cadmium and mercury. 
 
1.1.1.2 Mercury 
Among all metallic elements, mercury is the only liquid at standard temperature 
conditions; it appears in two oxidation states: elemental mercury (Hg0), and mercuric 
10 
 
state (Hg2+) (27). 
In the most oxidized state mercury can bind one or two carbons originating stable 
organic molecules, among which methylmercury (CH3Hg+) is the more toxic and 
represented (28,29). 
In the Middle Ages, the alchemical practices caused substantial poisoning from 
mercury, which was known, at that time, as ”quick silver”. 
In the last century, other poisoning effects has been detected, for example, the 
neurotoxic effects deriving from fumes of mercury as a professional pathology of the 
leather tanners. 
Due to its physical properties, mercury is used in the manufacturing of barometers, 
thermometers, hydrometers, pyrometers, UV lamps and many other special tools 
(30,31). 
Other fields of use of Hg include the production of mirrors, gold and silver 
extraction, electrical rectification (32,33). 
In addition, tattoo pigments, protective paints, pesticides and medicines 
(Thymesoral) may contain mercury (34-37). 
Lastly, there is a source of iatrogenic exposure to mercury which is given by dental 
amalgams, used until a few years ago in dental practice. Scientific research 
demonstrate that it is possible to correlate excreted urine mercury after chelation 
therapy with the number of such amalgams (38). 
As a result of human industrial activities, mercury is diffused into the environment 
as vapor, falling to the ground with rains, then accumulating in surface waters (37). 
Despite the main source of mercury vapors is the earth's crust, industrial vapors are 
the ones most absorbed by man as the main cause of environmental pollution (39). 
Indeed, it has been shown that human activities have caused a steady rise in mercury 
vapors over the last two centuries (40-42). 
Once emitted, mercury tends to accumulate in saline and soft waters and is converted 
here by methanogenic bacteria into methylmercury. In this form, the metal enters the 
food chain bioaccumulating into larger concentrations from microorganisms to 
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predatory fish (42) (figure 4). 
 
 
 
Figure 4: biogeochemical cycle of mercury (42) 
 
Mercury dust and its vapors enter the body through the respiratory system, via the 
gastrointestinal tract and the skin (43,44). 
There are two possible types of intoxication: acute and chronic. The first case causes 
abdominal pain, nausea, vomiting, enteric and kidney damage and death within 10 
days (43,44). 
Chronic intoxication, on the other hand, appears variable in symptoms, including 
muscle tremor, spasms at the extremities, mouth inflammation, gums, and falling 
teeth (43,44). 
Mercury causes a pronounced lipid peroxidation of red blood cells in the hemopoietic 
system, probably inhibiting the activity of glutathione peroxidase (GPX) and 
superoxide dismutase (SOD) (45). 
Several cases of interaction between the element and the immune system are reported 
in the literature: Hg not only has the ability of immunosuppression, but there is 
evidence that it can also yield immunostimulatory signals in various species, 
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including humans and rodents (46). 
The formation of immunocomplexes is the cause of renal impairment of 
glomerulonephritis reported on both guinea pigs (47) and humans (48). 
At last, there is an observable alteration of the nervous system which manifests with 
irritable behavior, apprehensive states, mood swings, depression, memory disorders, 
learning problems, impairment of social behavior, and low intelligence quotient (49). 
Also, the neurotoxic effect is very relevant on adults and fetuses, as described above 
paragraph 1.1.1 . 
 
1.1.1.3 Cadmium 
Cadmium has a rather recent story when compared to lead and mercury: it was 
discovered in 1817 and it has been used in the industrial field starting from the half 
of the XX century. It can be used to produce batteries, fertilizers, and pigments for 
paints and plastic materials and in the galvanization processes. Moreover, cadmium 
is a residual product of extraction processes of other metals (50). 
The main way cadmium is absorbed by the human body isthrough the gastroenteric 
system. Cadmium accumulates in cultivated plants, on polluted soils or by irrigation 
with water; from here, it gradually biaccumulates in the food chain (51). It can also 
be accumulated in a very efficient way by shellfish and mollusks (52). 
Also, the cigarette smoke represents an important source of exposure: according to 
some estimates, a cigarette contains from 1 to 2 ug of cadmium and about 10% of it 
is inhaled (53). 
Cadmium shows strong nephrotoxicity even if the origin of this process is indirect. 
In fact cadmium, after its enteric absorption, goes to the liver in the bloodstream 
where it stimulates the synthesis of metallothionein (MT), which has the capacity to 
bind cadmium (figure 5). The complex Cd-MT is partly stored in the hepatocytes and 
partly transported to the kidneys, where it is accumulated in the lysosomes of the 
cells of this organ, and it causes necrosis (54). (figure 6) 
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Figure 5: Schematic structure of a metallothionein. The domain alpha coordinates four atoms of 
cadmium, while the domain beta joins three (54). 
 
Depending on the exposure, a person may manifest acute or chronic intoxication. 
The acute toxicity by ingestion of contaminated food can cause sickness, vomiting 
and abdominal pains, while, if it is due to vapor inhaling, it can cause pneumonia 
with pulmonary edema (52). 
The chronic intoxication can cause pathologies of the tubule and of the kidney 
glomerulus (55), damaging the metabolism of the vitamin D and of the PTH (56). 
 
Figure 6: A proposed model for the pathogenesis of the nephropathy caused by cadmium(54) 
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It is possible to have osteomalacia and osteoporosis caused by an interference with 
calcium metabolism, leading to bone deformation and pain which are typical of the 
"Itai-Itai" disease (12) (cfr paragraph 1.1.1). 
Moreover, there are hypertension, cardiovascular disorders, lymphocytosis and 
microcytic anemia-hypochromic, emphysema, chronic pulmonary obstruction and 
behavior alterations and intellectual deficit. 
Cadmium is classified as a category I carcinogenic by the International Agency for 
Research on Cancer (IARC) which is put in relation to lung cancer caused by 
cigarette smoke (57). 
 
1.1.1.4 Aluminum 
Aluminum is one of the elements which is the most present on our Planet because it 
is the third in abundance to form the earth crust. Its reactivity lets it join with +3 
valence to oxygen givers such as phosphates or citrates. 
It is normally present in inert forms, but in the last few decades, aluminum has 
become more bioavailable by acid rain which has accentuated the toxicity. 
Humans can absorb aluminum from different sources, especially at home. In 
particular, it can be absorbed by aluminum sheets or bowls used to pack food, dishes, 
cutlery, coffeepots or cans made of this metal (58). 
Dishes, in particular, can yield large quantities of aluminum if they are used to cook 
or eat acidic foods such as tomatoes and its derivatives. 
Aluminum is also present in some medicines such as antacids, based on aluminium 
hydroxide , vaccines, which have been added with aluminum as an adjuvant, and 
some herbal compounds (59). 
Aluminum chloride is often used in drinking water processes to flocculate impurities 
(58), while aluminum chloride is used in cosmetics and deodorants as an astringent 
(59).  
Inside the human body, aluminum shows the most toxic effects on the respiratory, 
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gastroenteric, skeletal systems and on the central nervous system. In fact it interferes 
with the absorption of calcium, iron, and fluorides (60); in healthy patients, after the 
consumption of high quantities of antiacids, or in patients on dialysis, it has been 
shown to be a cause of osteomalacia due to its capacity to join phosphorus causing a 
lack of phosphates in the bones (61). 
It can also cause constipation due to the intestinal inhibition of peristalsis, caused by 
the interference with cholinergic signals (60). 
The consequences of the professional exposure to aluminum dust are mainly 
consisting in pulmonary fibrosis (62,63). 
The capacity of aluminum to join calmodulin can cause serious consequences on the 
nervous system, because of the alteration of the transport tubular activity. 
This last toxic activity seems to be particularly insidious and marked because it is 
connected to various neurologic and neurodegenerative pathologies, also depending 
on the age (64). 
Among the most emerging ones, there are the Alzheimer Disease, the Parkinson 
Disease (PD), the Amyotrophic Lateral Sclerosis (ALS), the Gulf War Syndrome 
(GWS), Autism Spectrum Disorders (ADS), the syndrome of Guam (complex ALS-
PD of Guam), the Dialysis Human Dementia Syndrome and other rare and less 
known diseases (64). Aluminum can substitute iron in some proteins (e.g. transferrin) 
(65,66), and it forms complexes with glutamate and citrate that can pass the blood-
brain barrier (BBB) (67,68), causing oxidative stress in the central nervous system. 
Referring to what has been explained hereabove, in 1989 a mixed committee of 
experts FAO/OMS about food additives (JECFA) has recommended a weekly 
provisional and tolerable dose (PTW) of 7,0 mg/kg body weight of Al, but this limit 
has been modified in 2007 by reducing it to 1.0 mg/kg body weight, because they 
have found some potential toxic effects on the developing reproductive system and 
on the nervous system (69). 
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1.1.1.5 Arsenic 
Even if it is not a real metal but a semi-metal, arsenic is such a diffused and toxic 
element that it is normally associated with the heavy metals class. In nature, it is 
diffused in both its oxidation states +3 and +5 which are normally forming inert 
mineral structures. The real danger consists in the environmental mobilization and 
dispersion of this element which, in this way becomes more reactive and absorbable. 
We can distinguish organic compounds from inorganic ones: the former can be 
further divided into trivalent (arsenic trioxide, sodium arsenite, arsenic trichloride) 
and pentavalent (arsenic pentoxide, ac. arsenic, lead and calcium arsenate) forms 
(70). 
The latter ones are present in both trivalent and pentavalent states and in methylated 
form, following the bio-methylation made by the microorganisms of soil and of salt 
and fresh waters (71). 
Arsenic is mainly dispersed in the environment by human activities, in particular as 
a byproduct of extraction and working of some metals as lead, copper, zinc, but also 
by the glass and chemical industry. There is also a specific arsenic compound, the 
copper acetoarsenite, also called "Paris green", added as preservative to chipboard 
and plywood (72). 
We can’t overlook the massive use, which was done in the past, of arsenic-based 
pesticides and herbicides which have dispersed huge quantities of this element in the 
soils and waters which were intended for agriculture. Even if today these products 
have been banned and replaced with other herbicides and organic pesticides, arsenic 
is still present and can be found in a lot of food, for example, rice (73). 
As any other xenobiotic elements, arsenic is metabolized by the liver and excreted 
by the kidneys. The hepatic metabolization in human body consists in the 
methylation of both the trivalent and pentavalent forms with production mono- and 
di- methyl arsenic (MMA and DMA). In this way, it is possible to obtain less toxic 
compounds which have a simpler excretion by kidney way (74). 
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In fact, the As(V) is reduced to As(III) which reacts with the S-adenosylmethionine 
(SAM) and is methylated to MMA and DMA (75). 
Arsenic changes the functionality of mitochondrial enzymes which are involved in 
the cellular respiration (76); in particular, it interferes with the action of the succinate 
dehydrogenase and it uncouples the oxidative phosphorylation. 
This causes an increase in the production of hydrogen peroxide which helps the 
formation of the different radical species (ROS), it causes damage to DNA and 
therefore potentially starts the development of cancer (74). 
Moreover, the chronic exposure to low amounts of arsenic can cause serious damage 
to human health: ailment, fatigue, dermatitis and eczema of allergic-type and, in most 
serious cases, hepatic injuries followed by jaundice, cirrhosis, ascites, and also 
neurological damages by demyelination of nerve fibers (77). 
A further danger of the chronic intoxication by arsenic is found in the mimic capacity 
of phosphorus which enables it to replace itself in the DNA, causing alterations in 
the structure and mutations. That's why  IARC and EPA classified it as carcinogenic 
(group I), respectively in 1987 and 1988 (78). 
 
1.1.1.6 Nickel 
Nickel is a ubiquitous metal which is mainly present as an oxide, sulfide, and silicate. 
There are several sources of exposure, for example, cigarettes, automotive exhaust 
gas, and certain kinds of food as chocolate, cocoa, soy, nuts, hydrogenated oils and 
coffee (79). 
Nickel can also be found in nickel-cadmium batteries (Ni-Cd), materials and 
prosthesis for dental use, costume jewelry and pigments for glass and pottery. 
The ordinary excretion of nickel is linked to the cysteine or other thiolic compounds 
(glutathione) or amino acids (histidine, aspartic acid, arginine) (80). 
Most of the absorbed nickel comes from drinks and food and the concentration can 
change a lot, according to the geographical area, the kind of diet and the water supply 
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(81). 
According to the chemical shape of the element and physiological factors, the 
absorption in the intestinal tract has a variation from 1% to 10%. The presence of 
nickel in the urine shows a recent exposure and changes a lot from day to day (82). 
The most clinically relevant manifestations are dermatosis, contact dermatitis, and 
atopic dermatitis (83). Moreover nickel exposure seems to hypersensitize the 
immune system, so promoting the appearance of allergic responses to various 
antigens (84). Finally, nickel changes enzyme functions replacing the zinc in the 
active sites of enzymes where it is the cofactor, by modifying the function (85).  
Nickel compounds are considered human carcinogens and metallic nickel is possibly 
a human carcinogen (86). 
A last important observation concerns an evident greater sensitivity to these effects 
in females. 
 
1.1.1.7 Rare Earth Elements (REE) 
Rare earths are a particular group of elements considered ideal candidates for 
georeferencing and traceability studies on food products (87). 
They are a group of 17 chemical elements, precisely scandium, yttrium and the 
lanthanides. Scandium and yttrium are considered rare earths because they are 
generally found in the same mining deposits of the lanthanides and they have similar 
chemical properties. 
The elements belonging to the REEs are found in the earth crust in relatively high 
concentrations, so the name "rare earths"  is not due to the abundance, but to the 
difficulty in extracting and separating processes. 
Lanthanides have aroused particular interest, because, due to their chemical 
similarity, they could not be submitted to phenomena of selective fractionation in the 
distribution of concentration from the soil, to the plant and finally to the fruit (the 
REEs do not have any role in the plant physiology) (88,89). 
This is particularly true regarding food products which do not undergo any 
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transformations before commercialization (vegetable products, saffron, raw nuts, 
etc). 
On the contrary, those products which derive from more complex processes (for 
example, wine), where the base product is transformed before the commercialization, 
can show an alteration in the REEs profile during transformation. In fact, in this case, 
it is necessary to consider the contribution of each process on the final REEs profile. 
 
1.1.2 Elemental Profiling 
Elemental profiling consists in the determination of all the elements contained in a 
sample; in line of principle, this profile includes all the elements (alkaline and 
alkaline-earth metals, transition metals, non-metals, lanthanides) but it is usually 
focused to the determination of heavy metals, potentially toxic elements (as Al, …..) 
and rare earths.  
To date, elemental profiling is a widely used approach in basic research; it usually 
exploits an inductively coupled plasma (ICP) for the atomization of the sample, 
coupled to mass spectrometry (ICP-MS) or to optical emission (ICP-OES or ICP-
AES) for the detection. ICP-MS represents a powerful tool for the quantitative 
determination of about 60 elements of the periodic table at trace (ppb-ppm) and ultra-
trace (ppb and sometimes ppt) concentration levels. 
This technique has many advantages: 
• in a single analysis it allows to determine the whole elemental profile of the 
analyzed sample 
• it allows very rapid analysis 
• it is able to detect minimum concentrations distinguishing different isotopes 
of the same element 
• it guarantees high sensitivity and reproducibility 
From the scientific literature it emerges that elemental profiling focuses mainly on 
two different research areas: health studies and food authentication and traceability 
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studies. In the first case it is used in the health field to monitor the concentrations of 
elements in biological samples such as urine, plasma, blood, hair, saliva, nails, tumor 
tissues (90-95), with the final aim of  confirming suspicions of chronic intoxication. 
Some recent studies relate different metals with neurodegenerative diseases such as 
Parkinson’s disease, Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS) and 
autoimmune diseases such as multiple sclerosis (MS) (96). Studies so far have 
involved in particular, lead, mercury, aluminum, cadmium  but a complete elemental 
profiling could shed on the correlation between the elements and their possible 
synergistic effects in influencing the onset, development and progression of these 
diseases, thus representing a significant step forward in their prevention and 
treatment. This area of research has developed in recent decades due to a strong and 
continuous introduction of metals and other elements into the environment. Some 
emblematic examples are: lead derived from petrol (97,98), mercury accumulated in 
fish (99,100), arsenic accumulated in rice (101). A further field of investigation has 
emerged in recent years concerning the dispersion of rare earth elements (REEs) in 
the environment due to components of computers, mobile phones and other last 
generation devices not properly disposed of. The replacement of mercury 
thermometers with thermometers using an alloy consisting of gallium, indium and 
tin represents a further potential source of metal pollution that is worth monitoring 
due to the unclear effects of these elements on human health (102,103). 
The second field of research that exploits elemental profiling is food science. In this 
case it can be used for the characterization of food from a nutritional point of view 
or for traceability and authentication studies of different food products.  
The elemental characterization of food can have a preventive function, both to avoid 
the excessive consumption of food at risk for heavy metals accumulation (e.g. 
mercury in tuna), and to encourage the consumption of food rich in micro and macro 
nutrients. 
In traceability studies, elemental profiling makes it possible to relate a product to its 
territory. Seeds and fruits are in facts a natural site of bio-accumulation of metals 
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inside the plant. Traceability studies usually involve the determination of REEs since 
these elements are accumulated by plants without being fractionated: the REEs 
profile of the soil is thus reflected in the fruit (104). This principle is at the basis of 
traceability studies, focused to verify if the REEs profile remains unchanged from 
the soil to the final product; this principle has already been demonstrated for some 
short supply chains, such as that of paprika (105). For the longer production chains, 
the maintenance of the REEs profile is not always verified and must be evaluated 
from time to time (106).  
On the other hand, in authentication studies for frauds identification, a link between 
food and territory is nor searched for but elemental profiling is used to differentiate 
equivalent food products from different areas without univocally binding them to the 
territory.  
 The amount of data obtained from elemental profiling does not allow a classic 
univariate approach to the problem, considering one variable (isotope) at a time (for 
example, the determination of 45 elements in 100 samples would lead to 4500 data), 
but rather makes it essential to apply techniques that provide a chemometric 
multivariate statistical treatment.  
Chemometrics is a branch of analytical chemistry focused to the development and 
application of statistical methods for problem solving and the analysis of data in the 
chemical field and more generally in applied sciences. 
Unlike most statistical and analytical procedures that tend to transform into 
univariate all the problems, even those that are intrinsically multivariate, this allows 
a multivariate approach to the system under investigation. Multivariate methods 
allow to take into account all the variables involved, making it possible to evaluate 
the correlations between the system descriptors and identify both synergisms and 
antagonisms.  
For the particular application to problems treated in this PhD thesis, two main tools 
of multivariate analysis were exploited (107): pattern recognition methods, useful 
for recognizing existing structures in the data, such as groupings present in samples 
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and / or variables with a similar behavior; classification methods, able to identify 
mathematical models for the differentiation of the samples in different classes. 
Pattern recognition tools are unsupervised methods, i.e methods where no a priori 
hypotheses are formulated on how the samples are grouped, aimed to  display data 
in a compact and easily readable way, so that the homogeneous groups can be 
recognized within the sample set. Among the unsupervised techniques, Principal 
Components Analysis (PCA) is undoubtedly the most widespread, together to cluster 
analysis (CA).  
Classification tools are instead supervised methods that, unlike the previous ones, 
are based on the assumption that the existence of groups or classes is already known 
and defined. This condition may derive from the fact that the samples are 
conceptually separated in theoretical classes or may derive from a previous 
identification of groups of samples by PCA or CA. Classification methods are aimed 
to identify the variables mostly responsible for the separation of the classes of 
samples, i.e. the identification of candidate markers. Each class is then described by 
a mathematical model that can be applied to unknown samples to evaluate their 
belonging to one class or another. Among the classification mostly exploited in 
traceability and authentication studies, we find Linear Discriminant Analysis (LDA) 
(108,109), Principal Component Analysis – Discriminant Analysis (PCA-DA) (108, 
109), Partial Least Squares – Discriminant Analysis (PLS-DA) (108,109) and Soft 
Independent Model of Class Analogy (SIMCA) (108,109).   
In literature, several papers are present about traceability and authentication studies 
exploiting multivariate statistics on elemental profiling For example, Aceto et al. 
(106) studied the possibility to use lanthanides (La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, 
Ho, Er, Tm, Yb, Lu) as chemical markers in a traceability study about the Moscato 
d'Asti wine production chain; soils, grapes and musts were analyzed by ICP-MS. The 
effect played by oenological practices on the REEs distribution was evaluated. In 
this work, PCA and CA were applied and proved that the lanthanides fingerprint is 
kept unaltered in the passage from soils to grapes and musts; alterations are instead 
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observed on the wine after clarification treatments using bentonites. 
Another paper Bontempo et al. (110) reports the possibility of tracing the 
geographical origin, in tomato and derivatives along the production chain (juice, 
passata and paste) by Isotope Ratio Mass Spectrometry, Inductively Coupled Plasma 
Mass Spectrometry and Ion Chromatography. The samples used in this study came 
from three different Italian regions (Piedmont, Emilia Romagna, and Apulia). The 
traceability of these products was demonstrated: excellent discrimination among 
products from the three regions was achieved by applying linear discriminant 
analysis (LDA) on 17 parameters (Gd, La, Tl, Eu, Cs, Ni, Cr, Co, d34S, d15N, Cd, 
K, Mg, d13C, Mo, Rb and U). 
Another study is about the Red Onion of Tropea (Calabria, Italy), an Italian product 
of excellence, registered on the European list of "Denominations of Origin and 
Protected Geographical Indications" on March 28, 2008 with Reg. CE n. 284/2008 
of the Commission (111); in this study, Furia et al. (112) developed a reliable 
classification model of onion samples in groups corresponding to “Tropea” and 
“non-Tropea” categories. The concentrations of 25 elements (Al, Ba, Ca, Cd, Ce, Cr, 
Dy, Eu, Fe, Ga, Gd, Ho, La, Mg, Mn, Na, Nd, Ni, Pr, Rb, Sm, Sr, Tl, Y, and Zn) in 
onion samples with PGI brand (120) and onion samples not cultivated following the 
production regulations (80) were analyzed by ICP-MS. Different chemometric 
approaches were tested: LDA SIMCA, and back-propagation artificial neural 
networks (BP-ANN). Satisfactory results (prediction ability >90%) were obtained.  
Finally, Spiros et al. (113) discriminated ‘‘Fava Santorinis’’ from other yellow split 
peas, by four classification methods applied to REEs and trace elements 
determination by ICP-MS. In this paper, orthogonal projection analysis (OPA), 
Mahalanobis distance (MD), PLS-DA and k nearest neighbors (KNN) were applied. 
OPA provided the best results 100% accuracy).  
When multivariate tools are applied to elemental profiling, particular attention must 
be paid to data pretreatment. Since the absolute concentrations of the elements 
usually decreases along the production chain, their use in traceability and 
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authentication studies is unfeasible. Elemental concentrations are usually 
normalized, that is scaled with respect to a reference analyte that has to remain 
unchanged in the samples under investigation. 
As for the elements to be used as normalizing factors, studies are present in literature 
that use as normalizing factors different elements such as strontium, barium, 
lanthanum or rubidium. The choice is usually driven by the fact that the chosen 
element must remain unchanged within the samples under analysis.  In other cases, 
the most adequate standardization factor needs to be identified in order to solve the 
problem. 
 
1.1.3 Chemometrics Theory 
Hereafter, the multivariate statistical methods used in this Ph.D. thesis will be briefly 
presented. 
1.1.3.1 Data pretreatment  
When multivariate techniques are applied, data pretreatment is usually necessary to 
provide reliable results. The most exploited scaling technique is autoscaling, 
consisting in a two steps procedure: data are first mean centered so that the new 
average value for each variable equals 0; then, the data are normalized by the 
standard deviation of each variable independently, so that the new variables have all 
unit variance. This scaling is useful to provide variables accounting for the same 
amount of information, thus eliminating scale effects.  
Here, autoscaling was always applied when applying PCA or other multivariate 
statistical techniques.  
When multivariate tools are applied in traceability studies based on elemental 
profiling, it is preferable to deal with ratios rather than with the absolute 
concentration of the elements since this last one naturally decreases passing from 
soil to the fruit and so on along the production chain. 
Data were therefore scaled for each analyte independently since each analyte could 
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be used as a normalizing factor, by the expression: 
𝑥𝑖,𝑗
′ =
𝑥𝑖,𝑗
𝑥𝑖,𝑘
 i≠k (1) 
where 𝑥𝑖,𝑗
′  is the normalized value for the i-th sample and the j-th analyte, 𝑥𝑖,𝑗 is the 
concentration level of the i-th sample and the j-th analyte and 𝑥𝑖,𝑘 is the concentration 
level of the i-th sample and the k-th analyte (where i≠k). 
 
1.1.3.2 Statistical Analysis: Principal Component Analysis (PCA) 
PCA (108,109) is a multivariate statistical method allowing the representation of the 
objects (samples), described by the original variables (metal concentrations), in a 
new reference system characterized by new variables called Principal Components 
(PCs). The PCs are calculated hierarchically: the first PC accounts for the maximum 
amount of the original variance, while subsequent PCs account for the maximum 
residual variance, so that systematic variations are explained in the first PCs, while 
experimental noise and random variations are contained in the last ones. Each PC is 
a linear combination of the original variables and they are orthogonal to each other, 
thus accounting for independent sources of information. PCA provides two main 
tools for data analysis: the scores, representing the co-ordinates of the samples in the 
space given by the PCs; the loadings, representing the coefficients of the linear 
combination describing each PC, i.e. the weights of the original variables on each 
PC. The scores allow the identification of groups of samples showing similar 
(samples close one to the other in the graph) or different (samples far from each 
other) behaviors. By looking at the corresponding loading plot, it is possible to 
identify the variables that are responsible for the similar or different behaviors 
detected for the samples in the score plot. PCA was applied here after varimax 
rotation of the most relevant PCs; this treatment allows the maximization of the 
variances of all the original variables on each PC (108,109). 
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1.1.3.3 Partial Least Squares – Discriminant Analysis (PLS-DA)  
Partial Least Square (PLS) (108,109) is a multivariate regression method 
establishing a relationship between one or more dependent variables (Y) and a group 
of descriptors (X). X and Y variables are modeled simultaneously, to find the latent 
variables (LVs) in X that will predict the LVs in Y. When a large number of 
descriptors (X variables) are present, or a large experimental error is expected, it can 
be quite difficult to obtain a final model with a suitable predictive ability. In these 
cases, techniques for variable selection are usually exploited. Here, a backward 
elimination (BE) strategy was applied, eliminating one variable at a time, according 
to the minimum error in cross-validation; variables are eliminated according to the 
smallest importance (114). PLS was originally proposed to model continuous 
responses, but it can be applied also for classification purposes by establishing an 
appropriate Y response  matrix related to the belonging of each sample to a class. 
The regression is then carried out between the X-block variables (here the elemental) 
and the Y just established. This application for classification purposes is called PLS-
DA (115,116). In this case, where three classes are present, three binary variables 
were added to the Y matrix, coded so that +1 means that the sample belongs to a 
certain cultivar corresponding to the specific column, while -1 means that the sample 
does not belong to the class associated to the specific column.  
 
1.1.3.4 Principal Component Analysis – Linear Discriminant Analysis (PCA-LDA) 
LDA (117-119) is a Bayesian classification method providing the classification of 
the objects taking into consideration at the same time the multivariate structure of 
the data.  Each object is classified in a particular class g if the so-called discriminant 
score Dg is minimum:  
𝐷𝑔(𝑥𝑖) = (𝑥𝑖 − ?̅?𝑔)
𝑇
𝑆𝑔
−1(𝑥𝑖 − ?̅?𝑔) + ln|𝑆𝑔| − 2 ln𝑃𝑔   (5) 
where, Sg is the covariance matrix of class g; ?̅?𝑔 is the centroid of class g, xi is the 
vector representing the i-th object and Pg is the prior probability of class g. In LDA, 
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Sg is approximated with the pooled (between the classes) covariance matrix; this 
corresponds to considering all the classes as having a common shape (i.e., the 
average, weighted over the degrees of freedom, of the shape of the present classes). 
The variables contained in the LDA model discriminating the classes can be chosen 
by a stepwise algorithm, selecting iteratively the most discriminating variables. Here, 
a forward selection (FS) procedure was applied: at each iteration, the variable 
guaranteeing the best Non-Error-Rate (NER%) in cross-validation was added to the 
final model. FS-LDA was applied to the principal components rather than to the 
original variables. The loadings of the PCs allow the calculation of the final weight 
of each original variable on the LDA model built on the PCs.  
  
1.1.3.5 Evaluation of the classification performances 
The classification performances can be evaluated both in fitting and cross-validation 
by the calculation of several indexes. The confusion matrix is a matrix reporting the 
true classes on the rows and the assigned classes on the columns. Given G classes, 
each element nkl represents the number of samples belonging to class k and assigned 
to class l. The diagonal values ngg, corresponding to each g-th class, are the correct 
assignments (i.e. samples correctly assigned to a class), while the extra-diagonal 
elements correspond to the miss-classifications (i.e. samples of a class erroneously 
attributed to another class). The sum of each row is the number of samples belonging 
to the corresponding g-th class (ng), while the sum of each column is the number of 
samples assigned to the corresponding g-th class (n’g). All the indexes related to the 
classification performances can be calculated starting from the confusion matrix: 
Precision is the capability of a classification model to not include samples of other 
classes in the considered class. For each class g, it is calculated as the percentage 
ratio of the number of samples correctly assigned to class g (ngg) and the total number 
of samples assigned to class g (n’g). 
Sensitivity is the capability of a classification model to correctly recognize samples 
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belonging to the g-th class. It is calculated as the percentage ratio of samples 
correctly assigned to class g (ngg) and the total number of samples belonging to class 
g (ng). 
Specificity is the capability of the g-th class to reject the samples of all the other 
classes. It is calculated as: 
𝑆𝑝𝑔 =
∑ (𝑛𝑘
′−𝑛𝑔𝑘)
𝐺
𝑘=1
𝑛−𝑛𝑔
∗ 100      for k≠g (3) 
where G is the number of classes and n'k is the total number of samples assigned to 
class k:  
𝑛′𝑘 = ∑ 𝑛𝑔𝑘
𝐺
𝑔=1    (4) 
Accuracy is the percentage ratio of the overall correctly assigned samples, 
considering all the classes contemporarily. 
The Non Error Rate (NER%) is the average of the class sensitivities, while the Error 
Rate (ER%) is the complement to 100% of the NER%. 
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2 CHAPTER 2 
 
2.1    Outline of the thesis 
The work of this Ph.D. Thesis is focused on deepening different aspect related to the 
exploitation of elemental profiling. The work was therefore divided into two main 
areas of research: the use of elemental profiling for the solution of issues related to 
human health and for the development of traceability and authentication studies.  
For what regards the use of elemental profiling in the area of human health, the study 
was focused on the monitoring for one year, by ICP-MS, of the excretion of heavy 
metals and other elements from a patient subjected to the chelating therapy with 
CaNa2EDTA. The main purposes of this study were the follow-up of the therapy and 
the evaluation of the efficacy of the employed administration protocol.  
The possible heavy metal chronic poisoning was hypothesized by the physicians, 
based on the anomalous clinical symptoms presented by the patient, which were 
apparently unrelated each other. A tentative diagnosis of Chronic Fatigue Syndrome 
was posed. The hypothesis was supported by the patient medical history and by 
laboratory investigations. In particular, the plasma level of lactic acid was constantly 
above the normal threshold, either at rest or under muscular stress. Such an alteration 
could arise from mitochondria malfunctioning in the muscles, caused by heavy 
metals intoxication. 
Paralel to this study, we have monitored for ten days the plasma proteome of this 
patient subjected to chelating therapy with CaNa2EDTA. The plasma proteins were 
analyzed with a micro-LC Eksigent Technologies  system (Eksigent, Dublin, USA) 
interfaced with a 5600+ TripleTOF system (AB Sciex, Concord, Canada) equipped 
with DuoSpray Ion Source and CDS (Calibrant Delivery System). The plasma 
proteome coverage was increased using immunodepletion method and the proteins 
were quantified using the label-free SWATH-MS quantification. The analysis 
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allowed to get insight into the expression of the plasma proteome changes after 
chelation therapy, providing new information in terms of the understanding of 
mechanisms and effects of the treatment on the human body, rather than the pathways 
involved. In fact, the low-abundant plasma proteins are considered an important 
source of biomarkers for disease diagnosis and therapeutic monitoring. 
The second part of the Ph.D. project envisages applying two different analytical 
techniques to perform hazelnut authentication and traceability studies. 
 It is very important for both the consumer and the food industry, to safeguard the 
protected varieties and the food quality. Due to the great commercial difference 
between the “Tonda Gentile delle Langhe” and the other cultivars, it is particularly 
important for the food industry the availability of tools for tracing the variety and the 
geographic provenance of hazelnuts and their derivatives along the production chain 
of the hazelnut paste. 
Here, we have applied elemental profiling through ICP-MS and ICP-OES in an 
authentication study involving the production chain of hazelnut paste: from raw 
fruits to roasted hazelnuts, down to the final paste. The study involves three different 
cultivars (“Tonda Gentile delle Langhe”, “Romana” and “Mortarella”) and the data 
were treated by multivariate statistical classification methods to provide a model able 
to discriminate the three cultivars independently from the type of technological 
transformation.  
The same raw hazelnut samples were also analyzed using a portable FTIR 
spectrometer coupled to multivariate statistical classification tools. 
With this method, we want to differentiate the hazelnuts from different cultivars 
based on the differences in the signal intensity of their IR spectra. 
Due to the rapid analysis, high sensitivity, simplicity and sample preparation, the 
proposed analytical methodology could be successfully used to verify the cultivar of 
hazelnuts, and the analysis can be performed quickly and directly on site. 
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3 CHAPTER 3 
“Elemental profiling and proteomic 
screening of urine and plasma during a 
chelating therapy” 
 
3.1 Introduction 
Metal ions are probably among the toxic agents known since the longest time. 
Differently from other toxic compounds, they cannot be created or destroyed, yet 
they can change their oxidation state. Their industrial extraction, transformation and 
wide use have favored the contamination of air, water, soil and food, and their 
subsequent introduction into the vegetal and animal food chain up to human 
organisms (1).  
Metals have spread in the environment following the widespread use of materials 
and substances in which they are present, such as gasoline and batteries (containing 
Pb), varnishes (containing Pb and Hg), pesticides (containing Pb, Hg and As), 
thermometers and teeth amalgams (containing Hg), pots, packages and cooking tools 
(containing Al), cigarette smoke (containing Pb and Cd) (2-9).  
Besides, Al and Hg are found also in vaccines and drugs (10-15). Other elements 
present in the environment due to anthropic pollution are Sn, Th, Ni, U, Ce, Ga, Sr, 
Co, Mo, Bi, Ti, Rb, Ag, W, Zr, Ba, Ge, V, Sb, La, Sc (16-18). 
While the toxicity of some elements (e.g. lead and mercury) is well known since 
centuries (19-24), in the last decades several compounds have been added to the list 
of the dangerous ones, like cadmium, aluminum and arsenic. These metals may 
accumulate in the body in targeted organs and cause organ failure following acute or 
chronic intoxication.  
Thanks to the intervention of public health care systems, the cases of severe metal 
poisoning by a single element are nowadays very rare. Instead, it is increasing the 
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attention towards the chronic effects due to the exposition to a mixture of metals (so-
called “cocktail effect”), individually at a concentration per se not sufficient to cause 
clinically relevant effects. 
One medical approach to contrast metal intoxication is the chelating therapy (25). 
The treatment consists in the infusion of chelating agents that are able to form soluble 
complexes with the metal ions present in the organism. Upon chelation, the metal 
ion loses its toxicity and is eliminated through the urinary route. However, the 
chelating agents present some undesirable features. For instance, they are not 
specific, and therefore can bind to either toxic and useful metal ions. In addition, 
they may cause inflammatory/allergic reactions (25). Further, the mobilization of the 
metal ions in form of complexes may redistribute the toxic metal ion through the 
circulatory system of the patient (26, 27). 
The ideal chelating agent for therapeutic application should have the following 
features: a) be soluble in water, b) not be metabolized, c) be able to reach the organs 
where the metals are stored, d) form stable and nontoxic complexes, e) be excreted 
through the urinary route, and f) show a low affinity for essential metal ions like 
calcium and zinc (28,29). Among the available agents (25,30), 
ethylenediaminetetraacetic acid (EDTA) is the most utilized one in the chelating 
therapy  (31-34), due to its low side effects  (35-40). EDTA is normally administered 
as calcium salt, since the disodium salt presents a high affinity for calcium and causes 
tetanic crisis due to hypocalcemia (40).  
The parenteral administration permits a fast distribution of the drug in the organism, 
while its absorption in the gastrointestinal tract is quite low.  
Furthermore, chelating therapy has been used for the treatment of several pathologies 
like artery diseases and neurodegenerative diseases. There are currently 11 FDA-
approved chelators available and EDTA is the most utilized (32).  
The role of metal toxicity in the pathogenetic mechanisms of hypertension, 
atherosclerosis, and coronary heart disease has already been highlighted (41). Toxic  
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metals induce oxidative stress, which is caused by unbalanced redox states, involving 
either excessive generation of reactive oxygen species (ROS) or dysfunction of the 
antioxidant system.  
The National Center for Health Statistics estimates that more than 100,000 
Americans receive chelation each year, but the inappropriate use of chelation therapy 
can be very dangerous (42). A large-scale controlled trial of disodium EDTA 
demonstrated the reduction of cardiovascular events (43): the treatment reduced 
clinical events in post–myocardial infarction (MI) patients, particularly in patients 
with diabetes  (44,45). Several studies showed the efficacy of the chelation therapy 
in removing metals intoxication but only few blood parameters related to the 
oxidative status have been investigated (46).  
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3.2 Chelating therapy for removing metal ions intoxications 
Here, we have monitored for one year, by ICP-MS, the excretion of heavy metals, 
from a patient subjected to the chelating therapy with CaNa2EDTA.  
The main purposes of this study were the follow-up of the therapy and the evaluation 
of the efficacy of employed administration protocol.  
The possible heavy metal chronic poisoning was hypothesized by the physicians, 
based on the anomalous clinical symptoms presented by the patient, which were 
apparently unrelated each other. A tentative diagnosis of Chronic Fatigue Syndrome 
was posed (47). The hypothesis was supported by the patient medical history and by 
laboratory investigations. In particular, the plasma level of lactic acid was constantly 
above the normal threshold, either at rest or under muscular stress. Such an alteration 
could arise from mitochondria malfunctioning in the muscles, caused by heavy 
metals intoxication  (48,49). 
 
3.2.1 Materials and methods  
3.2.1.1 The case history  
The patient is a 37 years old male subject, 1.80 m tall, actual weight 52 Kg, Body 
Mass Index (BMI) 16.04, non smoker, non alcohol or coffee drinker. He is presently 
under treatment with Eutirox 100 mcg/die. Following is the relevant clinical record:  
- 11 years old: development of a pollen allergy treated with desensitizing vaccines 
for about 20 years and an immunotherapy with allergenic extracts absorbed on 
aluminum hydroxide employed as adjuvant; 
- 11-29 years old: de-sensitizing vaccines (about 24 subcutaneous injections per 
year); 
- 23 years old: dietary allergies with anaphylactic shock (towards fruit and 
vegetables); 
- 24 years old: severe weight loss; frequent myalgia, arthralgia, muscle stretching; 
46 
 
- 31 years old: thyroid cancer (pT3m PN1a, total thyroidectomy + 2 cycles of 131I 
3.7 GBq and 5.5 GBq); osteoporosis;  
- 33 years old: elimination of the dental fillings containing mercury amalgams; 
- 35 years old: basal lactic acid at 15.95 mg/dL and up to 87.17mg/dL under stress, 
above the CUT-OFF values (normal range 5.7-22 mg/dL).  
However, analysis of a muscular biopsy from femoral quadriceps (in 2011), excluded 
the suspect of mitochondriopathy. Lead and aluminum were then determined in the 
patient blood, yet the values (lead 0.001 µg/mL and aluminum 0.0002 µg/mL) ruled 
out the possibility of an acute intoxication, given that the normal values for persons 
not professionally exposed to these heavy metals are < 0.0028 µg/mL and < 0.075 
µg/mL, respectively. 
Contemporarily, the dietary regimen of the patient was adjusted to limit as much as 
possible the intake of heavy metals.  
Notwithstanding the normal plasma levels, it was hypothesized an organ-specific 
accumulation of heavy metals. In 2012, the patient was submitted to a chelating test 
with EDTA, to evaluate the potential presence of heavy metals bio-accumulated in 
the organism. After the first chelating agent infusion, the urine samples collected 
within 12 h were analyzed by the Laboratory of Toxicology (Doctor’s Data Inc., St. 
Charles, IL USA). The 20 more toxic metals were determined by elemental analysis 
by inductively coupled plasma – mass spectrometry (ICP-MS). The concentrations 
of relevant metals were: Pb 15 µg/g creatinine (R.I. < 2 µg/g creat.), Cs 46 µg/g creat. 
(R.I. < 9 g/g creat.), Cd 2 µg/g creat. (R.I. < 0.8 g/g creat.), Ni 12 µg/g creat. (R.I. 
< 10 g/g creat.), Hg 3 µg/g creat. (R.I. < 3 g/g creat.), Tl 0.5 µg/g creat. (R.I. < 
0.5 g/g creat.) (figure 1a). 
Based on these results, it was advised to continue the chelating therapy, 
programming control analyses in the same laboratory at the 11°, 14°, 20° infusion. 
(Laboratory of Toxicology, Doctor’s Data Inc., St. Charles, IL USA) (figure 1b-d).  
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Figure 1: Mineralogram determined on the urine sample after the 1st (a), 11th(b), 14th (c) and 20th (d) 
infusion (Laboratory of Toxicology, Doctor’s Data Inc., St. Charles, IL USA).  
Meanwhile, the urine samples were collected every day, for seventeen months, with 
the aim to monitor in our laboratory the metals excretion along time and to analyze 
additional metals besides those considered by the Doctor’s Data lab. This systematic 
collection started at the 6th treatment. For the first five treatments, only the urines 
collected in the first twelve h post-therapy are available.  
 
3.2.1.2  Chelating therapy protocol  
The chelating therapy was administered every two weeks for a period of seventeen 
months. It consisted in slow intravenous infusion (3-4 hours) of 2g of EDTA as 
calcium-sodium salt (Salf, Brescia, Italia) diluted in 500 mL of physiological saline 
solution (46,50). 
a 
d c 
b 
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3.2.1.3 Sampling design  
Urine samples were collected as detailed below and stored in plastic bottles at 4°C 
until analysis. The collection was done as follow: 3 separate samples for the urine 
excreted every 12 h after the infusion and 3 separate samples for the urine excreted 
every 24 h up to the next infusion. From the 12th to the 30th infusion, the three 
separate 12 h samples were pooled in one single sample.  
The total amount of each element in the sample was normalized versus the duration 
time of the corresponding collection, so that the reference unit is g/h. 
Aliquots of each sample were preserved in Falcon tubes after supplementation of 2 
mL of 69% nitric acid. The samples were labelled with a four-digit code: a letter 
identifying the EDTA administration (F); a number identifying the progressive 
EDTA administration (1-30), a letter indicating the sample (C) and a number 
indicating the sample progressive order after the infusion (1-44; from 1 to 3, 12 h 
collection samples; from 4 on, 24 h collection samples). For example, sample F6C3 
refers to the sample collected after the 6th infusion, from 24 h to 36 h after treatment; 
sample F6C4 instead refers to the sample collected after the 6th infusion from 36 h 
to 60 h after treatment. 
 
3.2.1.4 Reagents and instrumentation   
EDTA as calcium-sodium salt (Salf, Brescia, Italia), Nitric Acid 69% Trace Select 
was from Fluka Analitical (Buchs, Switzerland), Multi-standard Solutions CCS1, 
CCS2, CCS4, CCS5, CCS6 for the calibration of the ICP-MS analysis was from 
Inorganic Ventures (Christiansburg, VA, USA), ultrapure water was obtained 
through a Millipore Milli-Q® system (Billerica, MA, USA, Microwave digester 
(Start D Microwave Digestion System, Milestone, Sorisole, Italy) and ICP-MS 
(XSeries 2 Thermo Scientific, Waltham, MA, USA) equipped with a single 
quadrupole mass analyzer. 
The instrumental signal acquisition parameters are reported in table 1. 
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 CCT-KED mode STD mode 
Extraction -161 -188 
Lens 1 -1150 -1150 
Lens 2 -87.1 -83.9 
Lens 3 -185.5 -187.5 
Pole Bias -17.9 -2.2 
Sampling Depth 130 150 
Horizontal 130 120 
Vertical 676 665 
Cool 14.8 14.8 
Auxiliary 0.82 0.82 
Nebuliser 0.9 0.92 
Forward power 1400 1400 
D1 -53.3 -40 
Focus -10.4 12 
CCT Gas 1 5 0 
D2 -122 -129 
DA -32.9 -31.4 
Hexapole Bias -20 -4 
 Survey Scan Setup Main Run Setup 
Sweeps 5 10 
Dwell Time 600 10000 
Channels Per Mass 10 1 
Channel Spacing - 0.02 
 
Table 1: ICP-MS experimental settings. Forward Power is expressed in W; Cool, Auxiliary and 
Nebuliser in L min-1; CCT Gas1 in mL min-1; Sweeps, Channel per mass, and Channel per spacing in 
arbitrary units; Dwell time in ms; all other parameters in V.  
 
Each calibration curve was calculated by means of the following seven standard 
solutions: 0.0001 gL-1, 0.001 gL-1, 0.01 gL-1, 0.1 gL-1, 1 gL-1, 10 gL-1, 100 
gL-1, covering a concentration range of 7 orders of magnitude. A weighted least 
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square fitting was used, weighting the errors by the inverse of the concentration level. 
Table 2 reports the LOD and LOQ for each investigated isotope, determined by the 
calibration curve method (51,52).  
 
Element LOD LOQ Element LOD LOQ Element LOD LOQ 
7Li 0.030 0.045 90Zr 0.015 0.040 159Tb 0.00010 0.00040 
27Al 0.020 0.060 93Nb 0.0013 0.0038 163Dy 0.00060 0.0020 
45Sc 0.061 0.092 95Mo 0.13 0.19 165Ho 0.00060 0.0018 
47Ti-CCT 0.40 1.3 98Mo 0.13 0.19 166Er 0.0013 0.0040 
47-Ti 0.13 0.40 103Rh 0.0012 0.0033 169Tm 0.00050 0.0020 
51V-CCT1 0.041 0.062 88Sr 0.048 0.072 172Yb 0.0015 0.0040 
52Cr-CCT1 0.024 0.073 89Y 0.0020 0.0060 175Lu 0.0010 0.0030 
55Mn-CCT1 0.0022 0.0066 105Pd 0.0070 0.020 178Hf 0.0020 0.0050 
56Fe-CCT1 0.34 0.52 107Ag 0.0090 0.027 180Hf 0.0020 0.0060 
59Co-CCT1 0.015 0.022 111Cd 0.0080 0.012 181Ta 0.0025 0.0075 
60Ni-CCT1 0.16 0.24 118Sn 0.010 0.040 182W 0.0011 0.0033 
62Ni-CCT1 0.14 0.20 120Sn 0.010 0.030 186W 0.0011 0.0034 
63Cu-CCT1 0.20 0.30 121Sb 0.0010 0.0030 187Re 0.0020 0.0060 
64Zn-CCT1 0.70 2.0 133Cs 0.025 0.038 193Ir 0.00080 0.0024 
65Cu-CCT1 0.16 0.25 138Ba 0.0040 0.020 195Pt 0.0050 0.0075 
66Zn-CCT1 0.70 2.0 139La 0.0010 0.0030 205Tl 0.00050 0.0014 
71Ga 0.0071 0.011 140Ce 0.0015 0.0050 206Pb 0.013 0.020 
72Ge 0.040 0.060 141Pr 0.00090 0.0030 207Pb 0.013 0.020 
74Ge 0.010 0.015 146Nd 0.0012 0.0035 208Pb 0.013 0.020 
75As-CCT1 0.14 0.21 147Sm 0.0010 0.0030 209Bi 0.0010 0.0030 
78Se-CCT1 0.50 0.80 151Eu 0.00010 0.0010 232Th 0.0020 0.0060 
78Se 0.30 0.40 153Eu 0.00040 0.0010 238U 0.00090 0.0030 
85Rb 0.0050  0.016 157Gd 0.0010 0.0030       
87Rb 0.014 0.040 158Gd 0.0011 0.0033       
 
Table 2: LOD and LOQ values for all isotopes expressed in gL-1. 
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Principal Component Analysis (PCA) and graphical representations were performed 
by Statistica v.10 (Statsoft Inc, Tulsa, OK, USA) and Unscrambler X (CAMO 
Software, Oslo, Norway). 
 
3.2.1.5 Optimization of the mineralization procedure 
The mineralization procedure underwent optimization by experimental design 
techniques: two levels were investigated for what regards the final concentration of 
HNO3 in the sample (2%W/W and 5%W/W). The mineralization at the two different 
concentration levels was repeated both using or not a microwave digester, providing 
4 experimental conditions. The microwave program was the following: to 180°C in 
15 minutes and 15 minutes at 180°C (maximum power 1200 W).  
For evaluating the best mineralization conditions three samples collected at the 23th 
EDTA infusion were used (F23C1, F23C2 and F23C3). Each experimental condition 
was applied to three different aliquots of each sample to evaluate the experimental 
variability. Each experimental replicate was evaluated by three instrumental 
replications. For all the samples the elemental profile was determined by ICP-MS, 
consisting in 59 different isotopes. All concentration levels inferior to the LOQ were 
substituted by zero. The data collected were treated by Principal Component 
Analysis (PCA) after autoscaling.  
Figure (2a) represents the score plot of the first two PCs (PC1 = 55% and PC2 = 23% 
of the overall variance): mineralization conditions with HNO3 2% are indicated as 
circles, while with HNO3 5% with triangles; the marker is white without microwaves 
while it is black if microwaves are used. The score plot indicates that PC1 mainly 
accounts for the differences between the three types of samples, notwithstanding the 
amount of nitric acid used for mineralization or the use of microwaves. 
Looking at the corresponding loading plot (figure 2b), it is possible to state that C3 
samples show a larger concentration of almost all the analytes (positive loadings on 
PC1) with the exception of Mn, Zn, Pb, Fe and Hf (negative loading on PC1), while 
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C1 and C2 samples show an opposite behavior.  Looking at the second PC, for all 
the three types pf samples the mineralization with 2% HNO3 is always at more 
negative scores than the treatment at 5%. The mineralization with NHO3 2% is 
particularly ineffective for Mn, Pb, Fe, Zn, Hf, Cu and Cr (positive loading on PC2). 
Moreover, at 2% the use of microwaves is not to be preferred. For what regards the 
mineralization with HNO3 5%, the use of the microwaves does not produce a 
significant effect. The mineralization of the samples with HNO3 5% and without the 
use of microwaves is to be considered the best choice. 
 
 
 
Figure 2: score plot (a), loading plot (b) 
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3.2.1.6 Determination of the elemental profile in urine samples 
All urine samples were treated as follows: 25.000 mL aliquots of the samples 
contained in the Falcon tubes were added with 1.385 mL of HNO3 69% (5% final 
concentration of nitric acid). The samples were diluted 1:5 v/v with ultrapure MilliQ 
water to obtain a 1% final concentration of nitric acid, and then analyzed with ICP-
MS. 
3.2.2 Results  
The temporal charts report the sampling order on the x axis and the total amount 
excreted, normalized vs the sampling time, on the y axis (g/h). Therefore, the total 
amount excreted is obtained by multiplying the y value for the collection duration 
time of the specific sample. 
The samples in the temporal charts are labelled according to five different classes: 
C1, C2, C3, C4 and “basal excretion”. While C1 to C4 indicate the first four samples 
collected after each infusion, the samples labelled as “basal excretion” correspond to 
all the others, collected beyond 60 h post-therapy (when its effect likely is 
terminated). Though in principle the latter could be affected by the chelating therapy, 
we can assume these as “basal excretion” since, after a rapid decrease in samples C1 
to C4, the concentration of metal excreted in these samples tends to become stable.   
For the sake of clarity, we shall discuss the analytes separately in the following four 
categories: 
• Toxic elements: Pb, Cd, Al, Cr, Cs, Tl, Rb, As, Ni, Ga, Sn, W. 
• Microelements: Mn, Zn, Fe, Cu, Se, Mo, Co 
• Rare earths: Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu.  
• Other elements: Hf, Ag Zr, Nb, Rh, Pd, Sb, Ba, Ta, Re, Ir, Bi, Li, V, Ti, Ge, 
Sr, Pt, Th, U. 
For all graphical representations, the samples are reported on the x-axis according to 
the increasing collection time, while the excretion (in g/h) is reported on the y-axis.  
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3.2.2.1 Toxic elements  
The temporal charts for the elements belonging to this category are reported in 
Figures 3-6.   
Pb, Cd, Al, Cr (Figure 3a-d) - For this group of elements there is a clear difference 
between sample C1 and the others. The chelating therapy shows very effective in the 
first 12 h samples (C1), where the concentrations of the four elements is very high 
in all the EDTA infusions. Pb concentration for the first samples slightly decreases 
after the 7th cycle of chelating therapy, and then it remains constant, though at levels 
much higher than the concentrations of the other samples. Five samples collected at 
36 h from the therapy show an excretion higher than the other samples of the same 
type (one of which shows Pb>1.2 µg/h). For Cd, the concentration of the first 
samples slightly increases along time, yet it is always much higher than for the other 
samples (0.09-0.20 µg/h). For Pb, the metal excretion within 12 h after infusion is 
almost constant (about 0.4 µg/h) for all the 30 treatments. From these data, we 
conclude that the chelating therapy sequestrates preferentially the tissue deposited 
Pb, rather than circulating Pb. A same consideration holds for Cd, though at a lower 
concentration level. Al shows an increase of the excretion in C1 samples (0.5-1.9 
µg/h). For Cr, the excretion in the first samples is in the range 0.02-0.05 µg/h, while 
in other samples are in the range 0-0.02 µg/h.  
The very few exceptions are the samples taken 36 h after the infusion, which show a 
high excretion (Cr >0.15 µg/h) with respect to the other samples of the same type 
(probably due to an accidental patient exposition). Same considerations hold for Pb.  
For Al, Cd and Cr, a daily excretion is also noticeable in samples collected beyond 
the 36h post-therapy. 
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Figure 3: Pb (a), Cd (b), Al (c), Cr (d) 
 
Cs, Tl, Rb (Figure 4 a-c) – These elements also show a clear difference between C1 
samples and the others. Cs excretion in the first samples decreases from the first to 
the 18th infusion (from 2.5 µg/h to 0.5 µg/h); for Tl the decrease is from 0.02 µg/h to 
0.005 µg/h, while Rb passes from 200 µg/h to 100 µg/h. All these three analytes 
show a relevant increase of the concentration in the first samples: after the 18th 
infusion for Cs and Tl, and after the 24th infusion for Rb. For the latter, the excretion 
corresponding to the first sample of the 30th EDTA administration is extremely high, 
reaching a level of 500 µg/h. The basal excretion of these elements has increased 
with respect to the first period of the chelating therapy, yet the samples of the first 
12 h constantly show an excretion higher than the others.  
 
a b 
c d 
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Figure 4: Cs (a), Tl (b), Rb (c) 
 
As, Ni, Ga (Figure 5 a-c) - These elements show an atypical behavior, in that 
apparently no effect of the chelating therapy is detectable. For Ni, the excretion 
varies in the range 0.4-1.6 µg/h up to the 15th EDTA administration and then 
decreases to 0.2-0.6 µg/h; for Ga, the excretion is of the same order of magnitude as 
for Cd (0.04-0.12 µg/h), following a peculiar trend. The behavior of As is variable, 
between 0.1 and 3.2 g/h. The patient’s diet with rice could have influenced the 
variable excretion of As.  
a b 
c 
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75As-CCT1 (ug/h)
 C1  C2  C3  C4 Basal excretion 
0 20 40 60 80 100 120 140 160 180 200 220 240 260 280
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
   
60Ni-CCT1 (ug/h)
 C1  C2  C3  C4  Basal excretion
0 20 40 60 80 100 120 140 160 180 200 220 240 260 280
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
 
71Ga (ug/h)
 C1  C2  C3  C4 Basal excretion 
0 20 40 60 80 100 120 140 160 180 200 220 240 260 280
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
 
Figure 5: As (a), Ni (b), Ga (c)  
 
Sn, W (Figure 6 a-b) - For Sn, in spite of the low excretion, a clear difference is 
evident between the first samples after the EDTA administration and the others, 
showing that the chelating therapy had a remarkable effect on this element. W shows 
an increase of its excretion in some of the first samples (e.g. for the 9th and 11th 
infusions). 
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c 
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Figure 6: Sn (a), W (b) 
 
3.2.2.2 Microelements  
Temporal charts of these elements are reported in figures 7 and 8.  
 
Mn, Zn, Fe, Cu (Figure 7 a-d) – The excretion of these elements is maximal in the 
first samples after the EDTA infusion for the whole treatment period, indicating that 
the chelating therapy is effective. The excreted amounts are within the range 600-
1000 µg/h for Zn, 1-1.8 µg/h for Mn, 27.5-30 µg/h for Fe and 1-3.5 µg/h for Cu. In 
the case of Cu, the amount excreted shows an increasing trend along time. The 
excreted amounts of Mn and Fe are higher than the basal amount also for the second 
and third samples after the EDTA administration, while for Zn only for the second. 
These data indicate that the maximal excretion is within the first 12 h, but their 
elimination remains higher than normal for at least 36 h after the treatment. These 
amounts for the second samples are within the range 0-50 µg/h for Zn, 0.18-0.5 µg/h 
for Mn and 3-8 µg/h for Fe. 
The amount of Zn released within the first 12 h after treatment is remarkable, 
between 600 and 1000 µg/h, which corresponds to an excretion of Zn of about 7.2 - 
12 mg within the first 12 h after the treatment (Zn RDA 15 mg/die) (53). 
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Figure 7: Mn (a), Zn (b), Fe (c), Cu (d) 
 
Se, Mo and Co (Figure 8 a-c) - These elements show a variable behavior along time. 
As for other elements, the excreted amount is larger for the first sample after the 
chelating therapy administration (particularly relevant for Co) and around the second 
half of the monitored period for Se. The basal elimination is very variable along time, 
especially for Se, whose excretion likely reflects the patient’s intake of supplements.  
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Figure 8: Se (a), Mo (b), Co (c) 
 
3.2.2.3 Rare earths and other elements  
Temporal charts of the excretion of the rare earths (Sc, Y, La, Ce, Pr, Nd, Pm, Sm, 
Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu) and other elements (Sr, Ti, Hf, Ag, Zr, Rh, Sb, 
Ba, Li, V, Ge, U) are reported in figures 9 to 15.  
Among rare earths and other elements, only the ones that present a significant 
behavior are reported; the other elements present significant excretion amounts only 
for some sporadic samples. Their presence can be related to a dietary effect, but 
nevertheless the chelating therapy seems to confirm its efficacy, at least for the first 
samples after the patient treatment. 
 
 
b a 
c 
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Sc (Figure 9) – its excretion is very variable, in the range 0.4-1.8 µg/h. Above all, in 
the second part of the treatment it can be observed a not very sensitive effect of the 
chelating therapy: the first samples after the chelating agent administration are 
always slightly more concentrated than the other ones.  
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Figure 9: Sc (a) 
 
La, Nd and Ce (Figure 10 a-c) - There is a noticeable excretion of these elements 
only for the first samples after the EDTA administration. This behavior can only be 
due to an accumulation of these elements in the patient’s tissues and organs, since 
the basal excretion is almost zero. 
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Figure 10: La (a), Nd (b), Ce (c) 
Sr and Ti (Figure 11 a-b) show a slight effect of the chelating therapy in C1 samples. 
The excreted amounts pass from 2 to 15 µg/h for Sr and from 30 to 120 µg/h for Ti 
(with a peak of 210 µg/h). The excretion of Ti is relevant: it must be remarked that 
during the therapy the patient consumed dietary supplements free from TiO2.  
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Figure 11: Sr (a), Ti (b) 
 
Hf, Ag, Zr (Figure 12 a-c) – The excretion of these elements resembles that of the 
rare earths La, Ce and Nd. In fact, there is a clear difference between the C1 samples 
and all the other samples, that present negligible amounts. The chelating therapy 
seems to be effective for the first 12h only, for their urinary elimination. As for La, 
c 
b a 
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Nd and Ce, this behavior can only be related to their accumulation in the patient’s 
tissues and organs, since no basal excretion is recorded. The amounts excreted for Zr 
equal those of Pb and the concentration levels are by far greater than for rare earths 
(0.001 µg/h for rare earths and 0.5 µg/h for Zr).  
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Figure 12: Hf (a), Ag (b), Zr (c) 
 
Rh, Sb (Figure 13 a-b) – They show a variable behavior, but the basal elimination is 
very small and very variable. There is a small effect of the chelating therapy as the 
first samples after the EDTA administration show larger excretion than the other 
ones.  
a b 
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Figure 13: Rh (a), Sb (b) 
 
Ba, Li, V, Ge (Figure 14 a-d) – These elements do not show the usual effect of the 
chelating therapy and are characterized by a variable excretion along time. There is 
no peculiar trend, with the exception of V that shows a decreasing excretion, with a 
slight effect of the chelating therapy on C1 samples in the second half of the patient’s 
treatment. The excreted amounts pass from 0.02 to 0.10 µg/h for Ba, from 0.05 to 
0.4 µg/h for V.  
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Figure 14: Ba (a), Li (b), V (c), Ge (d) 
     
U (Figure 15) – This element shows a detectable basal excretion only after the 8th 
administration. For the last infusions a slight effect of the chelating therapy on the 
C1 samples can be recognized. 
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Figure 15: U (a) 
 
3.2.2.4 Principal Component Analysis 
The data were arranged in a matrix of dimensions 288 x 70 (288 being the collected 
samples and 70 the isotopes determined by ICP-MS). The data were autoscaled and 
PCA was carried out by applying a varimax rotation to the first 7 PCs that explain 
about 65% of the overall information (PC1: 23.67%, PC2: 10.15%, PC3: 7.63%: PC4: 
d c 
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6.62%, PC5: 6.2%, PC6: 5.89%, PC7: 5.59%). The results confirm those obtained by 
the temporal charts already discussed, allowing the identification of groups of 
elements with a similar behavior: 
- Al, Mn, Zn, Fe, Y, Zr, Ag, Cd, Ce, Nd and Pb: characterized by an excretion 
that is completed within 12 or 24 h after treatment with a not negligible basal 
excretion. 
- V, Se, Ge, Rh, Ba, Mo, Ga, Ti, Sr, and U: characterized by an excretion that 
is larger 12h after treatment and a basal excretion that increases in the first 
half of the monitoring period and then decreases.  
- Nb, Pd, Ta, Hf, Ir, Th and Bi: characterized by an excretion that is larger 12h 
after treatment but with some samples characterized by a particularly large 
excretion. Rb, Cs and Tl: characterized by an excretion larger 12h after 
treatment but with a not constant basal excretion up to the 10th drip, then a 
considerable increase is recorded. This behavior could have two main causes: 
an increased assumption or an increased excretion induced by the chelating 
therapy.  
- rare earths: the excretion is completed within 12h after treatment and almost 
no basal excretion is recorded. 
- W, Ni, Sc and As: the excretion of these elements is larger in the first part of 
the treatment, also for what regards the basal values, then the basal excretion 
decreases; for the overall monitoring period, excretion after 12h is larger with 
respect to the other samples.  
Figures 16 to 22 report the loading and score plots of the first seven PCs calculated. 
The loading plots are reported separately for each PC: the loadings are reported on 
the y-axis while the original variable on the x-axis; the variables are represented by 
different symbols according to their belonging to the group of toxic elements, 
essential elements, rare earths or others. The score plots are also reported separately 
for each PC: the scores are reported on the y-axis while the samples on the x-axis, 
according to the order of collection; the samples are represented by different symbols 
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according to their belonging to C1, C2, C3, C4 group or to the group of samples 
characterized by basal excretion. In the score plots, the samples are reported on the 
x-axis according to the increasing collection time, while the scores along the 
corresponding PC are reported on the y-axis.  
Table 3 reports the % of explained variance and the % of cumulative explained 
variance for each PC (varimax rotated PCs were sorted and renamed according to a 
decreasing % of explained variance). The first 7 PCs explain about 65% of the overall 
information.  
Looking at the first PC (Figure 16 a), Al, Mn, Zn, Fe, Y, Zr, Ag, Cd, Ce, Nd and Pb 
show all positive loadings, while Sr shows negative loadings. The corresponding 
score plot (figure 16 b) shows that C1 samples are characterized by an excretion 
larger than other samples for the listed elements (the behavior is opposite instead for 
Sr); after the 10th drip also C2 samples show an excretion slightly larger than that 
corresponding to basal conditions. This behavior indicates for these elements an 
excretion that is completed within 12 or 24 h after treatment; however, basal 
excretion must not be neglected. 
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Figure 16 
 
PC2 (Figure 17 a) shows positive weights for V, Se, Ge, Rh, Ba (and in a minor way 
for Li, Co and Sr). As for the previous case, C1 samples (figure 17 b) show excretions 
a b 
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larger than that of other samples and in this case the basal excretion is quite variable: 
it increases in the first half of the monitoring period and then decreases.  
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Figure 17 
 
PC3 (Figure 18 a) shows positive weights for Nb, Pd, Ta, Hf, Ir, Th and Bi; the score 
plot (figure 18 b) highlights some samples characterized by a particularly large 
excretion but, zooming in the plot, C1 samples show again an excretion larger than 
other samples.  
 
Loading Plot PC3
Toxic Elements   Essential Elements    Rare Earths   Others
7
L
i
2
7
A
l
4
5
S
c
4
7
T
i-
C
C
T
1
4
7
T
i
5
1
V
-C
C
T
1
5
2
C
r-
C
C
T
1
5
5
M
n
-C
C
T
1
5
6
F
e
-C
C
T
1
5
9
C
o
-C
C
T
1
6
0
N
i-
C
C
T
1
6
2
N
i-
C
C
T
1
6
3
C
u
-C
C
T
1
6
4
Z
n
-C
C
T
1
6
5
C
u
-C
C
T
1
6
6
Z
n
-C
C
T
1
7
1
G
a
7
2
G
e
7
4
G
e
7
5
A
s
-C
C
T
1
7
8
S
e
-C
C
T
1
7
8
S
e
8
5
R
b
8
7
R
b
8
8
S
r
8
9
Y
9
0
Z
r
9
3
N
b
9
5
M
o
9
8
M
o
1
0
3
R
h
1
0
5
P
d
1
0
7
A
g
1
1
1
C
d
1
1
8
S
n
1
2
0
S
n
1
2
1
S
b
1
3
3
C
s
1
3
8
B
a
1
3
9
L
a
1
4
0
C
e
1
4
1
P
r
1
4
6
N
d
1
5
7
G
d
1
5
9
T
b
1
6
3
D
y
1
7
2
Y
b
1
7
8
H
f
1
8
0
H
f
1
8
1
T
a
1
8
2
W
1
8
6
W
1
8
7
R
e
1
9
3
Ir
1
9
5
P
t
2
0
5
T
l
2
0
6
P
b
2
0
7
P
b
2
0
8
P
b
2
0
9
B
i
2
3
2
T
h
2
3
8
U
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
 
Score Plot PC3
C1   C2   C3   C4   Basal excretion
0 20 40 60 80 100 120 140 160 180 200 220 240 260 280
0
20
40
60
80
100
120
 
Figure 18 
 
PC4 (Figure 19 a) shows positive loadings for Mo, Ga, Ti, Sr, Ba and U; for these 
elements the basal excretion is quite variable (it increases and then decreases) but 
a 
a b 
b 
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also in this case C1 samples are characterized by an excretion larger than the other 
samples (figure 19 b).  
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Figure 19 
 
The fifth PC (Figure 20 a) carries information about Rb, Cs and Tl. These elements 
show a particular behavior (figure 20 b): in general C1 samples show a larger 
excretion but in addition, basal excretion seems almost constant up to the 10th drip, 
then a considerable increase is recorded. This behavior could have two main causes: 
an increased assumption or an increased excretion induced by the chelating therapy.  
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Figure 20 
 
a 
a b 
b 
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The sixth PC (Figure 21 a) explains the contribution of a group of rare earths (La, 
Yb, Pr, Dy, Gd); the corresponding score plot (figure 21 b) shows some samples 
characterized by an extremely large excretion if compared to the other samples, and 
in general the excretion of C1 samples is larger than for other samples, in particular 
after the 10th drip. 
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Figure 21  
 
The 7th PC (Figure 22 a) shows the contribution of W, Ni, Sc and As (positive 
loadings). The excretion of these elements is larger in the first part of the treatment 
(figure 22 b), also for what regards the basal values, then the basal excretion 
decreases; however, for the overall monitoring period, C1 samples show a larger 
excretion with respect to the other samples. 
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Figure 22 
a 
a b 
b 
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3.2.3 Discussion  
Table 4 reports the total absolute amounts and the total amounts excreted within 12h, 
24h and after more than 24 h after the treatment, weighted for the collection time, 
for each element belonging to the four classes examined along the monitored period. 
 
Toxic elements 
Isotopes Total mg 
Excretion < 
12h (g/h) 
Excretion < 
24h (g/h) 
Excretion >24h 
(g/h) 
27Al 2.4 1.2 7.5E-1 2.2E-1 
47Ti-CCT1 6.4E2 9.1E1 8.2E1 6.5E1 
47Ti 6.5E2 9.3E1 8.4E1 6.7E1 
52Cr-CCT1 1.3E-1 3.6E-2 2.3E-2 1.3E-2 
60Ni-CCT1 5.4 6.6E-1 6.9E-1 5.6E-1 
62Ni-CCT1 5.5 6.7E-1 5.8E-1 5.7E-1 
71Ga 6.7E-1 9.2E-2 8.3E-2 6.9E-2 
75As-CCT1 7.2 9.2E-1 7.6E-1 7.5E-1 
85Rb 1.0E3 1.7E2 1.2E2 1.0E2 
87Rb 1.0E3 1.7E2 1.2E2 1.0E2 
111Cd 2.7E-1 1.3E-1 8.4E-2 2.4E-2 
118Sn 6.6E-2 2.1E-2 1.7E-2 6.0E-3 
120Sn 6.4E-2 2.1E-2 1.7E-2 6.0E-3 
133Cs 1.0E1 1.9 1.4 1.1 
182W 6.6E-2 9.0E-3 7.0E-3 7.0E-3 
186W 6.7E-2 9.0E-3 7.0E-3 7.0E-3 
205Tl 7.8E-2 1.3E-2 9.0E-3 8.0E-3 
206Pb 4.6E-1 4.4E-1 2.6E-1 3.2E-2 
207Pb 4.3E-1 4.1E-1 2.4E-1 3.0E-2 
208Pb 4.4E-1 4.2E-1 2.5E-1 3.1E-2 
     
Essential elements 
Isotopes Total mg 
Excretion < 
12h (g/h) 
Excretion < 
24h (g/h) 
Excretion >24h 
(g/h) 
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55Mn-CCT1 6.6E-1 1.4 8.3E-1 1.0E-2 
56Fe-CCT1 2.0E1 2.3E1 1.4E1 1.2 
59Co-CCT1 3.7E-1 5.4E-2 4.3E-2 3.8E-2 
63Cu-CCT1 4.7 1.9 1.2 4.3E-1 
64Zn-CCT1 5.1E2 7.9E2 4.4E2 2.3E1 
65Cu-CCT1 4.7 1.9 1.2 4.3E-1 
66Zn-CCT1 5.2E2 8.0E2 4.5E2 2.5E1 
78Se-CCT1 6.8E1 11.27 7.90 6.97 
78Se 7.1E1 11.80 8.26 7.30 
95Mo 6.3E1 9.8 9.1 6.3 
98Mo 6.4E1 1.0E1 9.3 6.5 
          
Rare earths 
Isotopes Total mg 
Excretion < 
12h (g/h) 
Excretion < 
24h (g/h) 
Excretion >24h 
(g/h) 
89Y 7.9E-4 2.2E-03 1.2E-03 n.d. 
139La 6.3E-4 7.8E-04 4.1E-04 4.0E-05 
140Ce 3.1E-3 7.5E-03 3.9E-03 6.0E-05 
141Pr 7.8E-05 9.1E-05 4.7E-05 5.2E-06 
146Nd 5.0E-4 1.1E-03 5.9E-04 1.2E-05 
147Sm 1.3E-05 3.8E-05 2.0E-05 n.d. 
151Eu 7.8E-06 2.2E-05 1.2E-05 n.d. 
153Eu 8.5E-06 2.5E-05 1.3E-05 n.d. 
157Gd 1.8E-05 5.3E-05 2.8E-05 n.d. 
158Gd 8.8E-06 2.5E-05 1.3E-05 n.d. 
159Tb 2.2E-05 4.5E-05 2.4E-05 6.6E-07 
163Dy 1.5E-05 4.2E-05 2.2E-05 n.d. 
165Ho 9.2E-06 2.6E-05 1.4E-05 n.d. 
166Er 7.7E-06 2.2E-05 1.1E-05 n.d. 
169Tm 9.5E-06 2.7E-05 1.4E-05 n.d. 
172Yb 3.9E-05 1.1E-04 5.9E-05 n.d. 
175Lu 7.3E-06 2.1E-05 1.1E-05 n.d. 
          
73 
 
Other elements 
Isotopes Total mg 
Excretion < 
12h (g/h) 
Excretion < 
24h (g/h) 
Excretion >24h 
(g/h) 
7Li 5.3 6.3E-1 5.4E-1 5.5E-1 
45Sc 8.3 1.1 9.1E-1 8.6E-1 
51V-CCT1 1.0 1.2E-1 1.0E-1 1.1E-1 
72Ge 7.0E-1 8.9E-2 7.3E-2 7.2E-2 
74Ge 6.4E-1 7.9E-2 6.0E-2 6.7E-2 
88Sr 5.5E1 2.5 3.0 5.9 
90Zr 1.8E-1 4.2E-1 2.3E-1 3.1E-3 
93Nb 5.1E-3 1.6E-03 1.1E-03 4.9E-04 
103Rh 5.3E-3 9.5E-04 6.3E-04 5.5E-04 
105Pd 7.5E-2 5.3E-03 6.3E-03 7.9E-03 
107Ag 4.8E-3 1.3E-02 6.9E-03 2.4E-05 
121Sb 1.6E-2 2.9E-03 2.3E-03 1.6E-03 
138Ba 2.7E-1 2.5E-02 2.3E-02 2.9E-02 
178Hf 6.4E-3 9.1E-03 5.1E-03 3.3E-04 
180Hf 6.1E-3 8.9E-03 5.1E-03 3.1E-04 
181Ta 5.9E-4 3.9E-04 2.4E-04 4.8E-05 
187Re 1.1E-3 1.0E-04 6.9E-05 1.2E-04 
193Ir 2.3E-4 1.0E-04 8.1E-05 2.0E-05 
195Pt 1.7E-3 2.3E-04 1.4E-04 1.8E-04 
209Bi 2.3E-4 1.9E-04 1.4E-04 1.6E-05 
232Th 2.5E-3 7.3E-04 6.8E-04 2.3E-04 
238U 5.2E-3 8.7E-04 6.9E-04 5.3E-04 
 
Table 4: Amount of analytes excreted during the overall period considered (Total mg), weighted 
excretion of the analytes expressed as g/h within 12h, 24h and after 24h after treatment. 
 
 The weighted amounts are calculated summing up the absolute amounts of the 
corresponding samples and dividing for the corresponding sum of collection time 
(expressed in h). The absolute amounts are indicated as total excreted mg, while the 
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weighted amounts are expressed as g/h. Some elements show a high total excretion, 
e.g. Zn (>500 mg), Ti (>600 mg), Rb (>1 g), Mo (> 62 mg), Cs (>10 mg), Sr (>55 
mg), Sc (>8 mg).  
Figures 23, 24, 25 and 26 represent the weighted amounts excreted within 12 h, 24 
h and after more than 24 h after treatment of toxic (figure 23), essential (figure 24), 
rare earths (figure 25) and other elements (figure 26).  
 
   
    
Figure 23: Bar diagrams of the weighted excretion (in ug/h) within 12h, 24h and after more than 
24h after treatment of each toxic element. 
 
   
0
0,5
1
1,5
2
2
7
A
l
6
0
N
i-
C
C
T1
7
5
A
s-
C
C
T1
1
3
3C
s
2
0
8P
b
12h 24h >24h
0
0,05
0,1
0,15
71Ga 111Cd
12h 24h >24h
0
0,01
0,02
0,03
0,04
52Cr-CCT1 186W 205Tl 120Sn
12h 24h >24h
0
50
100
150
200
85Rb
12h 24h >24h
0
0,5
1
1,5
2
55Mn-CCT1 59Co-CCT1 63Cu-CCT1
12h 24h >24h
0
200
400
600
800
64Zn-CCT1
12h 24h >24h
75 
 
 
Figure 24: Bar diagrams of the weighted excretion (in ug/h) within 12h, 24h and after more than 
24h after treatment of each essential element. 
 
    
 
Figure 25: Bar diagrams of the weighted excretion (in ug/h) within 12h, 24h and after more than 
24h after treatment of each rare earth. 
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Figure 26: Bar diagrams of the weighted excretion (in ug/h) within 12h, 24h and after more than 
24h after treatment of each other element. 
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constant or even very low values after 24 h of treatment. For these elements, 
however, the basal excretion is not negligible. This pattern is characteristic of a wide 
range of elements: Al, Ni, As, Cs, Ga, Cd, Cr, W, Tl, Sn, Rb (toxic elements); Co, 
Cu, Se, Mo (essential elements); Ti, Nb, Rh, Sb, U, Th, Sc (other elements). Peculiar 
patterns are observed for elements belonging to the fourth class:  
- V, Ge, Li, Ba, Pt, Re show a larger excretion within 12 h, a decrease within 24 
h and then an increase after 24 h. We conclude that these elements show an 
effect of the chelating therapy comparable with the basal excretion.   
- Pd and Sr show excretions after 24 h higher than in the first 24 h post-therapy. 
For these elements, the chelating therapy shows no significant effect.  
 
3.2.4 Conclusions  
The systematic collection of the urine samples for 17 months permitted to monitor 
the excretion of metals from the organism contemporarily identifying the anomalous 
excretions following the pharmacological treatment. The results confirm the efficacy 
of the chelating therapy in the elimination of the heavy metals accumulated in the 
organism, as indicated by the fact that the majority of the elements shows an 
excretion peak in the 12 h after the EDTA administration. 
For metals as Cd, As, Al, Cr, Rb, Ti, and others, the excretion continues also 36 h 
after the treatment, showing a pattern defined as “basal excretion”. The ICP-MS 
analyses confirm, on the other hand, the results of the mineralograms, and further 
provide a clearer view of the situation, with the evidence of an increased number of 
bioaccumulated elements, e.g. Rb (1.0 g in 17 months), Ti (0.65g in 17 months), Sr 
(0.055 g). The large excretion of Rb, whose toxic effect has been scarcely 
investigated, is worth of further investigation in order to clarify the origin of its 
presence in the patient’s body and its potential patho-physiological effects.  
It is worth of note that microelements such as Zn, Mn, Fe and Cu (and in a minor 
way for Co), which act as co-enzymes and co-factors, were eliminated in the C1 
78 
 
samples. Thus, it is advisable to introduce adequate dietary supplements in the time 
interval between two EDTA administrations, in order to restore the reservoir of these 
elements and so avoiding side-effects from their depletion. In fact, the protocol used 
in the present treatment excludes the intake of vitamins and minerals, since they 
might reduce the EDTA effect. 
From a mere clinical point of view, the utility of the chelating therapy was further 
confirmed by the improvement of the general conditions of the patient that after the 
8th treatment reported 3 main effects: 1) improvement of his memory, concentration 
capability and muscular strength, with a decrease of the joints instability; 2) 
restoration of physiologic libido; 3) decrease of the dietary intolerances, with 
reintroduction in his diet of foods that were previously causing allergic reactions. 
The positive effects reported by the patient became stable after the 20th chelation. 
Since then, he has continued the treatment with EDTA for 10 further administrations. 
After 15 months from the last chelation therapy, the positive effects are only slightly 
reduced. 
Two general conclusions arise from the present study:  
1. The unhealthy condition of the patient was not attributable to a chronic 
intoxication from a single element. Instead, the tissue accumulation of a 
mixture of elements possibly contributed to the Fatigue syndrome-like 
symptoms.  
2. The chelating protocol could be implemented to optimize EDTA chelating 
efficacy and to minimize the collateral effects. In fact, the effect of EDTA 
almost ends within 24 h after the treatment (25).  
Further to be considered is the unbalance between administered EDTA and elemental 
excretion: the overall amount of EDTA administered equals 0.146 mol, while the 
overall elements excreted are about 0.0072 mol (calculated within 24 h after EDTA 
administration). It follows that EDTA is administered (at least in this case) at a very 
high dose with respect to the amount effectively exploited for metals chelation. Thus, 
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a more frequent and low-dose administrations of EDTA could be more effective and 
less harmful.  
Another strategy (54) consists in exploiting a combination of two chelating agents 
with different mechanisms of action. This approach, known as “Combination 
Therapy”, improves the mobilization of the metals from the body, reducing the dose 
of the chelating agent potentially toxic and avoiding the re-distribution of the toxic 
metals between different body organs (55). An example (56) is given by the 
combined administration of monoisoamyl DMSA (MiADMSA) and EDTA in mice: 
this strategy is effective to limit lead chronic toxicity, reducing the amount of lead 
in the body and avoiding the death of neural cells. 
To our knowledge, the data here reported represent the most complete dataset 
regarding the long-term monitoring of a chelating therapy. The present results 
provide insights on the therapy effects and suggest some adjustments to improve its 
strength and efficacy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
3.3 Plasma proteome profile during a chelating therapy 
The analysis of blood proteins is very important in order to understand a disease 
pathway and to identify biomarkers, but also to evaluate the effect of a therapy. Low-
abundant plasma proteins are considered the most promising biomarkers for disease 
diagnosis and for therapeutic monitoring. To this aim, several immunodepletion 
methods for the reduction of high abundant proteins were developed during the last 
decade and, today, they are widely employed in discovery studies (57).  
None of the previous studies were however performed to investigate the expression 
of the plasma proteome changes after chelation therapy. Such feature may indeed to 
a large extent provide new general information in terms of the understanding of 
mechanisms and effects of the therapy on the plasma proteome rather than on the 
pathways involved.  
In the present study, we have monitored for ten days the plasma proteome of a patient 
with heavy metal chronic poisoning subjected to the chelating therapy with Ca-Na-
EDTA. The plasma proteins were quantified using shotgun proteomics: the 
concentration of the most abundant proteins was reduced by immunodepletion 
method in order to increase the proteome coverage and to quantify the low-abundant 
one. The samples were analyzed using the label-free SWATH-MS quantification 
method (58,59) and the results were processed using statistical and bioinformatic 
tools. 
 
3.3.1 Materials and Methods 
3.3.1.1 Chelating therapy protocol, subject and plasma collection  
The chelating therapy protocol and the subject were already described in paragraphs 
3.2.1.1 and 3.2.1.2. 
Blood samples were collected during the three days before the chelation treatment 
and one, two and six days after the therapy. Plasma samples were obtained from 3 
ml of fresh blood, obtained by venipuncture and centrifugation at 400×g. Each 
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plasma sample was harvested and separated into aliquots and frozen at −80°C until 
the analysis. 
 
3.3.1.2 Plasma sample preparation 
Twelve μL of plasma were depleted of high abundant proteins using the Seppro 
IgY14 spin column kit (Sigma-Aldrich Inc., St. Louis, MO, USA) following the 
manufacturer protocol. The method is used to bind human serum HSA, IgG, 
fibrinogen, transferrin, IgA, IgM, haptoglobin, alpha2-macroglobulin, alpha1-acid 
glycoprotein, alpha1-antitrypsin, Apo A-I HDL, Apo A-II HDL, complement C3 and 
LDL (ApoB) and thus to increase the identification of low-abundant proteins. The 
sample was transferred into an Amicon Ultra-0.5 mL 3 kDa centrifugal filter 
(Millipore, Billerica, MA, USA) following the manufacturer protocol, to collect the 
high molecular weight proteins. The sample was then subjected to denaturation with 
TFE (trifluoroethanol), to reduction with DTT (dithiothreitol) 200 mM, alkylation 
with IAM (Iodoacetamide) 200 mM and the complete protein trypsin digestion with 
2 μg of Trypsin/Lys-C (Promega, Madison, WI, USA). The peptide digests were 
desalted on the Discovery® DSC-18 solid phase extraction (SPE) 96-well Plate (25 
mg/well) (Sigma-Aldrich Inc., St. Louis, MO, USA). The SPE plate was 
preconditioned with 1 mL of acetonitrile and 2 mL of water. After the sample 
loading, the SPE was washed with 1 mL of water. The adsorbed proteins were eluted 
with 800 μL of acetonitrile:water (80:20 v/v) (60). After desalting, the sample was 
vacuum evaporated and reconstituted with 20 μL of 0.05% formic acid in water. 2 
μL of stable-isotope-labeled peptide standard (DPEVRPTSAVAA, Val- 13C515N1 
at V10, Cellmano Biotech Limited, Anhui, China) was spiked into the samples 
before the LC-MS/MS analysis, and used for the instrument quality control (61). 
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3.3.1.3 LC-MS/MS analyses 
The plasma proteins were analyzed with a micro-LC Eksigent Technologies  system 
(Eksigent, Dublin, USA) that included a micro LC200 Eksigent pump with flow 
module 5-50 µL, interfaced with a 5600+ TripleTOF system (AB Sciex, Concord, 
Canada) equipped with DuoSpray Ion Source and CDS (Calibrant Delivery System). 
The stationary phase was a Halo C18 column (0.5 x 100 mm, 2.7 µm; Eksigent 
Technologies Dublin, USA). The mobile phase was a mixture of 0.1% (v/v) formic 
acid in water (A) and 0.1% (v/v) formic acid in acetonitrile (B), eluting at a flow-
rate of 15.0 µL min−1 at an increasing concentration of solvent B from 2% to 40% in 
30 min. The injection volume was 4.0 μL and the oven temperature was set at 40 °C. 
For identification purposes the samples were subjected to a data dependent 
acquisition (DDA): the mass spectrometer analysis was performed using a mass 
range of 100–1500 Da (TOF scan with an accumulation time of 0.25 s), followed by 
an MS/MS product ion scan from 200 to 1250 Da (accumulation time of 5.0 ms) with 
the abundance threshold set at 30 cps (35 candidate ions can be monitored during 
every cycle). The ion source parameters in electrospray positive mode were set as 
follows: curtain gas (N2) at 25 psig, nebulizer gas GAS1 at 25 psig, and GAS2 at 20 
psig, ionspray floating voltage (ISFV) at 5000 V, source temperature at 450 °C and 
declustering potential at 25 V.  
For the label-free quantification the samples were subjected to cyclic data 
independent analysis (DIA) of the mass spectra, using a 25-Da window: the mass 
spectrometer was operated such that a 50-ms survey scan (TOF-MS) was performed 
and subsequent MS/MS experiments were performed on all precursors. These 
MS/MS experiments were performed in a cyclic manner using an accumulation time 
of 40 ms per 25-Da swath (36 swaths in total) for a total cycle time of 1.5408 s. The 
ions were fragmented for each MS/MS experiment in the collision cell using the 
rolling collision energy. The MS data were acquired with Analyst TF 1.7 software 
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(AB SCIEX, Concord, Canada). Two DDA and three DIA acquisitions were 
performed (61-63).  
 
3.3.1.4 Protein database search 
The DDA files were searched using Protein Pilot software v. 4.2 (SCIEX, Concord, 
Canada) and Mascot v. 2.4 (Matrix Science Inc., Boston, USA). Trypsin as the 
digestion enzyme was specified for both the software. For Mascot we used 1 missed 
cleavages, the instrument was set to ESI-QUAD-TOF and the following 
modifications were specified for the search: carbamidomethyl cysteines as fixed 
modification and oxidized methionine as variable modification. A search tolerance 
of 50 ppm was specified for the peptide mass tolerance, and 0.1 Da for the MS/MS 
tolerance. The charges of the peptides to search for were set to 2+, 3+ and 4+, and 
the search was set on monoisotopic mass (64). The UniProt Swiss-Prot reviewed 
database containing human proteins (version 2015.07.07, containing 42131 sequence 
entries) was used and a target-decoy database search was performed. False Discovery 
Rate was fixed at 1% (61).  
 
3.3.1.5 Protein quantification 
The quantification was performed by integrating the extracted ion chromatogram of 
all the unique ions for a given peptide. SwathXtend was employed to build an 
integrated assay library, built with the DDA acquisitions, using a protein FDR 
threshold of 1% (65). The quantification was carried out with PeakView 2.0 and 
MarkerView 1.2. (ABSCIEX, Concord, Canada).  Six peptides per protein and six 
transitions per peptide were extracted from the SWATH files. Shared peptides were 
excluded as well as peptides with modifications. Peptides with FDR lower than 1.0% 
were exported in MarkerView for the t-test (61). 
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3.3.1.6 Bioinformatics and Statistics Software  
The identified proteins were classified with PANTHER Classification System (66). 
The regulated proteins were analyzed by using STRING software (67), which is a 
database of known and predicted protein-protein interactions. For functional 
annotation clustering and network analysis of proteins, the Cytoscape 3.1.0 plug-ins 
ClueGO v2.0.8 was also used (68). Statistical analysis was carried out with 
PeakView 2.0 and MarkerView 1.2. (ABSCIEX, Concord, Canada) (61). 
 
3.3.2 Results 
In this research the plasma proteomic profile of a patient with heavy metal chronic 
poisoning was monitored for ten days before and after the chelating therapy with 
CaNa2EDTA, as reported in figure 27. The blood samples from the analysis of the 
three days before the therapy allowed to obtain a very robust control baseline of the 
patient plasma proteome, that was then compared with the proteome after the therapy 
with the aim of understanding the mechanisms of action, the effects and the pathways 
involved during the chelating therapy. The plasma samples were depleted of the high 
abundant proteins and subjected to proteolytic digestion. A peptide liquid 
chromatography separation followed by mass spectrometry analysis and database 
search with Protein Pilot and Mascot was then performed. SWATH-MS analyses 
were performed in triplicates for each analyzed sample and were imported in the 
PeakView software to perform the label-free quantification and the identification of 
regulated proteins. The data were also analyzed using multivariate analysis, for 
instance, principal component analysis – discriminant analysis (PCA-DA). 
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Figure 27. Workflow of the research: the plasma proteome was monitored during three days before 
the therapy and until 6 days after the treatment. The highly-abundant proteins were reduced with the 
immunodepletion method, the proteins were then digested, analyzed with LC-MS and identified and 
quantified across the 10 days. Bioinformatic software were employed to extract the more important 
information related to the regulated proteins and the pathways involved. 
The LC-MS analysis allowed the identification of 265 proteins. The gene ontology 
classification of the identified proteins was carried out to characterize the plasma 
proteome profile of the dataset. Figure 28 shows the distribution of the proteins based 
on cellular components, molecular functions and biological processes. The two most 
abundant functions represented are catalytic activity (42%) and binding function 
(36%). Some few proteins associated to the antioxidant activity are also present 
(1%). Proteins related to cellular (19%) and metabolic processes (14%), together 
with the response to stimulus (11%) are also well described in the samples. 
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Figure 28. Gene Ontology classification of the identified proteins based cellular component, 
biological process and molecular function.  
The proteins fold change of the samples collected after one, two and six days from 
the therapy were calculated against the average values of the three days before the 
treatment: a total of 58 proteins were differentially expressed in the three days after 
the treatment. 
The heat map represented in figure 29a shows the trend of the fold change for the 58 
regulated proteins: in the first day 19 proteins resulted up-regulated, while 22 were 
down-regulated, 17 proteins on the 58 are not regulated in the first day; in the second 
day 13 proteins were down expressed and 7 up regulated; after 6 days 16 proteins 
were down and 6 up regulated. 17 proteins were commonly regulated over the days 
as shown in the histogram of figure 29c that represents the log10 fold change of these 
proteins for each day.  
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Protein accession Protein names Gene 
FC 1 
DAY vs 
PRE 
FC 2 
DAYS vs 
PRE 
FC 6 
DAYS vs 
PRE 
A1BG_HUMAN Alpha-1B-glycoprotein A1BG 0.63 - - 
AFAM_HUMAN Afamin AFM - - 1.43 
APOC2_HUMAN Apolipoprotein C-II APOC2 0.61 0.70 0.68 
APOC3_HUMAN Apolipoprotein C-III APOC3 0.46 0.62 0.56 
APOE_HUMAN Apolipoprotein E APOE - 0.73 - 
C1RL_HUMAN Complement C1r subcomponent-like protein C1RL - - 0.69 
C4BPA_HUMAN C4b-binding protein alpha chain C4BPA 1.94 - - 
CAH1_HUMAN Carbonic anhydrase 1 CA1 0.49 0.60 0.51 
CAH2_HUMAN Carbonic anhydrase 2 CA2 0.19 - - 
CBPN_HUMAN Carboxypeptidase N catalytic chain CPN1 0.77 - - 
CFAI_HUMAN Complement factor I CFI - 0.74 - 
CO2_HUMAN Complement C2 C2 0.23 - - 
CO8B_HUMAN Complement component C8 beta chain C8B 0.68 0.73 - 
CO9_HUMAN Complement component C9 C9 0.53 - - 
FA12_HUMAN Coagulation factor XII F12 0.54 0.76 0.72 
FCGBP_HUMAN IgGFc-binding protein FCGBP - 1.43 - 
FETUB_HUMAN Fetuin-B FETUB 0.63 - - 
FHR2_HUMAN Complement factor H-related protein 2 CFHR2 1.32 - - 
GELS_HUMAN Gelsolin GSN 0.66 - 0.76 
GPX3_HUMAN Glutathione peroxidase 3 GPX3 0.53 0.68 0.70 
HEMO_HUMAN Hemopexin HPX 1.62 0.73 1.41 
HGFA_HUMAN Hepatocyte growth factor activator HGFAC 0.58 - - 
HV201_HUMAN Immunoglobulin heavy variable 2-70 IGHV2-70 - - 0.76 
HV206_HUMAN Immunoglobulin heavy variable 4-39 IGHV4-39 2.62 - - 
IGJ_HUMAN Immunoglobulin J chain JCHAIN 1.33 - - 
IGLL5_HUMAN Immunoglobulin lambda-like polypeptide 5 IGLL5 1.49 - - 
ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 ITIH1 - - 1.42 
ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 ITIH4 - - 1.45 
K1C10_HUMAN Keratin, type I cytoskeletal 10 KRT10 - - 0.36 
K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal KRT2 - - 0.41 
K2C1_HUMAN Keratin, type II cytoskeletal 1 KRT1 - - 0.35 
KAIN_HUMAN Kallistatin SERPINA4 0.63 - - 
KLKB1_HUMAN Plasma kallikrein KLKB1 1.45 1.36 1.37 
KNG1_HUMAN Kininogen-1 KNG1 0.74 - - 
KV118_HUMAN Immunoglobulin kappa variable 1-17 IGKV1-17 - 2.58 - 
KV121_HUMAN Immunoglobulin kappa variable 1D-33 IGKV1D-33 1.63 - - 
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KV122_HUMAN Immunoglobulin kappa variable 1-16 IGKV1-16 1.74 - - 
KV206_HUMAN Immunoglobulin kappa variable 2-30 IGKV2-30 1.36 - - 
KV311_HUMAN Immunoglobulin kappa variable 3-11 IGKV3-11 2.47 - - 
KV402_HUMAN Immunoglobulin kappa variable 4-1 IGKV4-1 1.39 - - 
LAC2_HUMAN Immunoglobulin lambda constant 2 IGLC2 1.35 - - 
LUM_HUMAN Lumican LUM 0.62 - 0.73 
LV104_HUMAN Immunoglobulin lambda variable 1-51 IGLV1-51 1.43 - - 
LV301_HUMAN Immunoglobulin lambda variable 3-1 IGLV3-1 - 2.03 - 
LV401_HUMAN Ig lambda chain V-IV region Bau  2.10 2.29 - 
LYAM1_HUMAN L-selectin SELL 0.72 0.75 - 
N4BP2_HUMAN NEDD4-binding protein 2 N4BP2 - - 0.51 
PEDF_HUMAN Pigment epithelium-derived factor SERPINF1 0.51 0.75 - 
PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase PGLYRP2 0.63 - - 
PLSL_HUMAN Plastin-2 LCP1 0.25 0.64 - 
RET4_HUMAN Retinol-binding protein 4 RBP4 0.58 0.73 0.61 
SAMP_HUMAN Serum amyloid P-component APCS 2.50 1.60 - 
STEA3_HUMAN Metalloreductase STEAP3 STEAP3 - - 0.19 
TM156_HUMAN Transmembrane protein 156 TMEM156 1.65 - - 
TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 TRIM33 - 1.79 - 
TTHY_HUMAN Transthyretin TTR 1.81 - - 
VTDB_HUMAN Vitamin D-binding protein GC 2.36 - 2.36 
ZA2G_HUMAN Zinc-alpha-2-glycoprotein AZGP1 - - 0.23 
 
Table 5: protein accessions, protein names, genes and fold changes of the modulated proteins 1, 2 
and 6 days after the chelating therapy. 
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Figure 29. Heat map of the fold changes of the regulated proteins after one, two and six days after 
the therapy (a); Venn diagram (b) and histogram (c) of the common regulated proteins. 
 
The 58 regulated proteins were submitted to the web-based tool Cytoscape to 
visualize the non-redundant GO terms and pathways in functionally organized 
networks: the resulting image, as shown in figure 30, reflects the relations between 
the biological terms based on the similarity of their linked gene/proteins. The 
analysis revealed the presence of four functional clusters linked to the complement 
activation, lipoprotein metabolic protein, coagulation and cellular response to metal 
ion. Among these four groups, the complement activation cluster is the most 
prominent and the proteins included in it are up and down regulated; the proteins 
related to coagulation, lipoprotein and cellular response to metal ion are all down 
regulated. 
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Figure 30: Cytoscape representation of functional clusters of regulated proteins. 
 
The interactions and network analysis of regulated proteins was performed using the 
STRING software: the analysis showed four different groups reflecting the results 
obtained from Cytoscape, as reported in figure 31. 
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Figure 31: STRING network analysis of regulated proteins. 
 
The multivariate analysis performed using the PCA-DA method showed that the 
blood samples obtained before the therapy are quite similar among them and that 
their variability is very small. Figure 32a shows the score plot of the first two latent 
variables describing the dataset: the samples are correctly separated into the four 
classes, and in particular the first dimension is able to discriminate the “pre” and 
“post” state. The samples obtained before the therapy (grey) are grouped together 
and are well separated from the samples after the treatments. The sample obtained 
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one day after the therapy (green) is the farther from the controls, followed by the 
second day sample and the six days one, which is the closest to the pre-treatment 
state.  
 
Figure 32. Score plot (a) of the plasma samples before (grey) and one (green), two (red) and six 
(orange) days after the therapy. Loading plot (b) of the plasma samples.  
 
3.3.3 Discussion 
During the chelation therapy the metal ions in the human body are chelated and 
eliminated through the urinary route. But this is not the only effect of EDTA on 
human body and plasma. The therapy is also widely used to treat heart diseases 
because the chelating agent can binds the calcium ions present in the fatty deposits 
in the arteries, which may be then swept away through the bloodstream. 
As reported in the STRING and Cytoscape analysis, the main pathways related to 
modulated proteins are the complement activation, the blood coagulation, the 
lipoprotein process and the proteins linked to the metal activity. The proteins related 
to this two last classes are the most important for cardiovascular and metal 
intoxication pathologies. 
For what concerns the effect of the chelating therapy on proteins related to metal ions 
and metal intoxication, elements like Pb and Cd have a high affinity for –SH groups 
in enzymes and anti-oxidative defense system and thus inhibit their activity. 
Moreover, the levels of glutathione (GSH), which is one of the most important 
components of antioxidant protection, are affected by metal intoxication.  
PRE 
1	DAY	POST 
6	DAYS	POST 
2	DAYS	POST 
A B 
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Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme 
that uses excess H2O2, helping to maintain the redox balance in cells (69). During 
the reaction, GSH is oxidized to glutathione disulfide (GSSG). Fulgenzi et al. 
showed that the chelation treatment improved the oxidative and metabolic 
parameters in patients affected by neurodegenerative diseases, demonstrating an 
increase of GSH levels after the therapy (70). Our data suggests that the increasing 
of GSH levels may be caused by a decrease of the glutathione peroxidize, in 
particular the GPX3, which catalyzes the GSH oxidation. GPX3 is down-regulated 
because metals are chelated by EDTA and eliminated through the urinary route: thus, 
their concentration decreased together with the synthesis of GPX3, which is one of 
the major scavenger of ROS in plasma.  
Plasma glutathione peroxidase concentration has also been found elevated in 
rheumatoid arthritis (71) and a recent paper demonstrated the efficacy of chelating 
therapy on this pathology (41): our findings suggests that there may be a link between 
the down-regulation of GPX3 caused by the treatment and the successful 
management of rheumatoid arthritis by chelation therapy. 
We also observed the down-regulation of lumican (LUM), a proteoglycan 
component which binds to collagens and that was identified as overexpressed in 
rheumatoid arthritis with respect to spondyloarthropathy (72). It has been also 
implicated as an atherosclerotic marker that induces collagen fibrillogenesis in 
coronary atherosclerosis (73) and it has also key roles in tumor development and 
progression (74).  
Metallothionein (MT) is a ubiquitous family of metal-binding proteins that are 
critical to the homeostatic control of metal levels. Since MT was discovered it has 
been implicated in toxic metal detoxification, oxidative stress response, and essential 
metal homeostasis (75). Fully saturated Zn-MT is capable of donating zinc to the 
apoenzymes such as Carbonic anhydrase protein (CAH1), which is a zinc-containing 
enzyme that catalyzes the reversible hydration of carbon dioxide, the first discovered 
metalloenzyme. The zinc ion can be removed from these isozymes by dialysis 
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against certain chelating agents (76). In our research, the concentration of CAH1 
decreased after the chelation treatment, suggesting an inactivation of the enzyme 
after the zinc chelation.  
Another important aspect of the effect of chelation therapy on human health is the 
one related to the reduction of cardiovascular risk. Our analysis demonstrated for the 
first time that the biochemical network linked to lipoprotein processes is down-
regulated, in particular the Apolipoprotein Apo C-III (APOC3), Apolipoprotein Apo 
C-II (APOC2) and retinol-binding protein 4 (RET4) are down-expressed after the 
treatment. An excess of APOC2 has already been associated to increased 
Triglyceride-rich particles and alterations in the High Density Lipoprotein (HDL) 
particle distribution, factors that may increase the risk of cardiovascular diseases 
(77). Moreover, several studies showed the associations of circulating RET4 with 
obesity, insulin resistance, type 2 diabetes and cardiovascular risk factors (78). As 
shown in figure 7, after 6 six days the levels of APOC3, APOC2 and RET4 were still 
down-regulated. The role of EDTA on the removal of xenobiotic metals and its 
association with the cardiovascular risk factor has already been highlighted (79): our 
results unveiled the mechanism of how chelation can reduce major cardiovascular 
events. 
One more protein of interest is the Pigment epithelium-derived factor (PEDF), which 
is a member of the serpin family secreted by adipocytes, found overexpressed in 
obese children and adults. Recently, elevated PEDF in children with type 2 diabetes 
mellitus was attributed to obesity (80). After the chelation treatment, PEDF protein 
is down-regulated.   
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Figure 33. Box-plot of common regulated proteins after six days of treatment: while some proteins 
are still modulated after six days the concentration of few of them reached the basal level. 
 
3.3.4 Conclusions 
The aim of the present study was to understand the mechanisms of action, the effects 
and the pathways involved during the chelating therapy on a patient with heavy metal 
chronic poisoning. The plasma proteome of the patient was monitored through 
shotgun proteomics for ten days. Although this research is limited to only one 
chronic patient, this is the first study where the effect of EDTA on plasma proteome 
has been considered.  
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Our results showed a significant modulation of proteins related to redox balance in 
cells and elimination of ROS in plasma. Moreover, for the first time, we shed light 
on the mechanism of how chelation can reduce major cardiovascular events. In fact, 
although the effect of EDTA on cardiovascular diseases has been already studied by 
several projects and consortium, its effect on the broad plasma proteome was never 
considered. The results obtained with the shotgun proteomic approach allowed us to 
identify with high confidence the down regulation of proteins related to lipoprotein 
processes (APOC3, APOC2 and RET4), which are associated to high cardiovascular 
risk.  
The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE (81) partner repository with the 
dataset identifier PXD006284. 
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4 CHAPTER 4 
Traceability and authentication of hazelnuts 
and their products 
4.1 Introduction 
Hazelnuts are dried fruits particularly rich of group B vitamins, phosphorous, copper, 
calcium, proteins and essential fatty acids (1-4). For their high content of proteins 
(about 20%) and lipids (about 60%), hazelnuts are a valid substitute for dressings 
and plastic ingredients of animal origin and are therefore exploited for preparing oils 
and different specialties in the food industry: confectionery, nougat, candies, creams 
etc. In these applications hazelnuts are usually exploited as whole fruits, small grains, 
flour or oil, that are in turn used to produce paste, cream and other finished products. 
However, hazelnuts are also becoming widespread as nutraceutical ingredients, due 
to their content of phytosterols, recently related to the prevention of cardiovascular 
diseases (1,3,5-8). Recent studies confirmed, for example, that a regular 
consumption of hazelnuts can decrease the level of LDL cholesterol and triglycerides 
(1-3, 9-11).  
Turkey, Spain, Italy and France are among the most important producers of hazelnuts  
(1,2,12,13); in 2014, FAO reports that the most important producers were Turkey, 
followed by Italy, Georgia and USA, other emerging producers being Azerbaijan, 
China, Iran, followed by Spain and France (12,14). The finest Italian varieties are:  
- “Tonda Gentile Trilobata” (or “Tonda Gentile delle Langhe”). This is a 
Protected Geographic Indication (PGI) variety, cultivated in several districts of 
the provinces of southern Piedmont (Alessandria, Asti and Cuneo - Italy). The 
fruit is characterized by: a round shape that improves the efficiency of the 
mechanical shelling; delicate and characteristic aroma and flavor; a reduced 
content of fats that limits its rapid rancidity; a thin film surrounding the fruit, 
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easily removable after roasting. It is worldwide considered as the best variety 
and presents by far the largest prices on the market. Among all the varieties 
cultivated in the world, this variety is characterized by a very high commercial 
value since it is particularly suitable for confectionery (15,16) (European 
commission regulation (EC) No 1107/96 on the registration of geographical 
indications and designations of origin): its round shape makes its peeling very 
easy after roasting, so that tannins-reach peels do not affect taste (they are 
particularly bitter) when hazelnuts are transformed into paste; moreover, the 
high content of oleic acid and monounsaturated rather than polyunsaturated fatty 
acids, in particular with respect to cultivars from other countries, makes it more 
easily storable (17); finally, its quite thin shell guarantees a high yield (15,16) 
(European commission regulation (EC) No 1107/96 on the registration of 
geographical indications and designations of origin). In 1996 the TGL obtained 
the Protected Geographical Indication (PGI) from the European Union (EU) 
under the name “Nocciola Piemonte” (European commission regulation (EC) 
No 1107/96 on the registration of geographical indications and designations of 
origin) (18). 
- “Tonda Gentile Romana”. The shape of this variety is slightly elongated and 
sub-spheroidal. The fruit is medium-small, while the shell is quite thick. It is 
cultivated in some districts of the provinces of Rome and Viterbo (Latium, 
Italy). 
- “Mortarella”. This variety produces sub-cylindrical medium-small fruits. The 
shell is quite thin. The fruit is very aromatic, with a white-ivory pulp. This 
variety is cultivated in almost all areas of Campania region (Italy), above all for 
the transformation industry. It represents almost 30% of the overall Italian 
national production.  
- “Tonda di Giffoni”. Also this variety has the PGI certification and it is cultivated 
in several districts of the province of Salerno (Campania, Italy). Its fruits are 
108 
 
perfectly round, the pulp is white and the flavor is aromatic. It is particularly 
suitable for roasting and peeling. For these characteristics, this variety is 
particularly suitable for industrial transformations into grain and paste. 
From an international point of view, these Italian varieties must deal with other ones 
characterized by a great commercial diffusion, as those cultivated in Turkey 
(Tombul, Cakildak, Mincane, Karafindik, Palaz and others) or Spain (Negret, 
Gironell, Pautet, Culplà, Tonda di Giffoni, Morell).  
Hazelnuts are widespread in the food industry either as whole fruits, small grains, 
flour or oil, to produce paste, cream and other finished products, above all in 
confectionery. Different hazelnut cultivars show a different commercial value, the 
cultivar “Tonda Gentile delle Langhe” produced in Italy being by far the most 
valuable. Along the industrial production chain, hazelnuts first undergo a process of 
roasting to exalt their aroma, and then hazelnut paste is produced by a fine grinding 
of the peeled fruits. 
Due to the great commercial difference between the “Tonda Gentile delle Langhe” 
and the other cultivars, it is particularly important for the food industry the 
availability of tools for tracing the variety and the geographic provenance of 
hazelnuts and their derivatives along the production chain of the hazelnut paste.  
 
4.1.1 The production chain of hazelnut paste 
Along the industrial production chain, hazelnuts must first undergo a process of 
roasting to exalt their aroma. Roasting has the purpose of dehydrating and oxidizing 
the fruits to increase storage time and prepare them to the different uses. It is 
necessary not only to improve the organoleptic properties of hazelnuts, but also for 
inactivating the action of microorganisms, delaying in this way their degradation. 
The heat treatment itself, besides the alteration of the aroma profile (19, 20) can 
cause modifications of vitamins (21,22), carotenoids (21), phytosterols (22), 
tocopherol (21), lipids (22) and fatty acids (22,23), altering both the organoleptic and 
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the nutritional properties of hazelnuts. For these reasons, temperature and time of 
roasting must be accurately controlled. Two industrial approaches are available to 
accomplish this step:  
- static roasting (24) performed on tin pans in conventional ovens for 20-25 
minutes at around 180 °C; 
- dynamic roasting (25), performed in rotary or hot air flux ovens for 25-35 
minutes at around 140°C. With this method heat is transferred in a more 
homogeneous way, favoring peeling.  
Roasted hazelnuts are often further transformed into hazelnut paste both for direct 
human consumption and for confectionery; this process involves a fine grinding of 
the peeled fruits to provide a very fluid product.  
While it is possible for the experts to distinguish between different hazelnuts 
varieties from a visual inspection of the entire fruit, unfortunately this is no more 
possible when the fruits are reduced to grain or paste. 
 
4.1.2 Tools for the traceability and authentication of hazelnuts 
From a commercial point of view, it is particularly important for the food industry 
to achieve tools for tracing the variety and the geographic provenance of hazelnuts 
and their derivatives, also along the transformation chain. Due to the quite different 
commercial value of the different varieties, studies on hazelnuts traceability and 
authentication are of great importance to promptly identify commercial frauds. 
Besides the commercial reasons, food safety hints are also gaining the attention of 
the consumers who are increasingly interested in traceable food for reducing the risk 
of food-borne diseases (26). 
Traceability and authentication of typical foodstuffs has recently gained increasing 
attention and many papers have appeared focusing on the possibility to use different 
chemical characterization tools in traceability and authentication studies of different 
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foods (27-40). Elemental and stable isotopes profiling are certainly the most 
widespread techniques in this field and have been successfully applied to 
characterize favas (28), paprika (29), tomatoes (30), onions (31), clementines (32), 
cereals (33), oranges (35), honey (34, 36), saffron (38), olive oil (39, 40) and melons 
(41). 
Different analytical methods have been applied for the classification of hazelnuts 
according to the different cultivar (14,42-47).  
Many papers are present reporting the use of genomic approaches, as real-time 
polymerase chain reaction (PCR) (42-45).  
However, other analytical approaches have recently been proposed, as near infrared 
(NIR) spectroscopy (46) or 1H Nuclear Magnetic Resonance (NMR) (14, 18). 
Cordero et al. (47) focused on the profiling of volatiles by comprehensive two-
dimensional gas chromatography coupled to mass spectrometry, while Ciarmiello et 
al. (48) applied High Performance Liquid Chromatography (HPLC) to determine the 
phenolic profile. In the field of omics techniques, Locatelli et al. (49) used a genomic 
approach combined to a physical-chemical characterization and a protein 
fingerprinting by SDS-PAGE; Klockmann et al. (50) exploited metabolomics 
through Ultra Performance Liquid Chromatography Quadrupole Time-Of-Flight 
Mass Spectrometry (UPLC-QTOF-MS).  
For what regards elemental techniques, Oddone et al. (51) applied elemental and rare 
earths profiling. A couple of studies are present in literature reporting applications 
of elemental profiling in authentication and traceability studies to the production 
chain of tomato products (30) and wine (52), but no studies are present referred to 
hazelnut products.  
Spectroscopic techniques are also widely employed for food quality and safety 
inspections: the analysis is non-destructive and can exploit the physical-chemical 
information on the analyzed products (53,54). Visible and near infrared (NIR) and 
attenuated total reflectance (ATR) spectroscopies have already been used for 
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assessing the cultivar of a specific food and for authenticating the geographical origin 
of many products (55-58). Among the spectroscopic techniques, FTIR spectroscopy 
allows the detection of small differences and changes in structure and properties of 
biomolecules like proteins, carbohydrates and lipids altogether, when present in 
biological tissues and cells (59). While a recent study showed that NIR spectroscopy 
coupled to chemometrics was able to classify hazelnuts according to their geographic 
origin (60), FTIR spectroscopy has already been used to characterize the radiation-
induced changes in the macro-molecular composition, concentration and structure of 
hazelnuts (61). The major components of lipids from hazelnuts are triacylglycerols 
and phospholipids, that can be detected by IR analysis. The chemical lipid profile 
(particularly triacylglycerols) has already been used to identify hazelnut oils on the 
basis of their country of origin (62). For example, French cultivars were found to be 
richer in triacylglycerols containing linoleic acid, while the American ones resulted 
richer in saturated fatty acids, since the triacylglycerol composition can be influenced 
by environmental factors (18). 
 
4.1.3 Multivariate tools for the traceability and authentication of 
hazelnuts 
In food science, multivariate screening methods and classification techniques have 
been successfully employed in the identification of food adulterations (63-65) and in 
food authentication (66-68). Principal Component Analysis (PCA), a multivariate 
pattern recognition method, has already been applied to describe the geographic 
provenance in a compact and efficient way (52). Lerma-García and coauthors (69) 
classified oil samples from five different botanical origins (EVOO, sunflower, corn, 
soybean and hazelnut) by linear discriminant analysis (LDA). Moscetti and 
coauthors (70) used k-nearest neighbours (KNN), soft independent modelling of 
class analogy (SIMCA), Partial Least Squares – Discriminant Analysis (PLS-DA) 
and support vector machine discriminant analysis (SVMDA) to discriminate 
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hazelnuts on the basis of the PDO ‘Nocciola Romana’ regulation. The best results 
were obtained with SVMDA and PLSDA, that showed very good recognition 
performances (with a classification accuracy > 95%) (18). 
 
4.1.4 Challenges in the traceability and authentication of hazelnuts  
Currently, the identification of the origin of raw hazelnuts remains a great problem 
for the food industry. Here, we faced this problem from two different points of view: 
on one hand, the use of elemental profiling for the authentication and the traceabilty 
of hazelnut cultivar along the production chain of hazelnut paste; on the other hand, 
the use of a simple, fast and accurate analytical method for their classification and 
authentication, based on IR spectroscopy, able to   perform non-destructive analyses 
on the samples, with an environmentally friendly sample preparation (71).  In both 
cases, multivariate classification tools were applied to build authentication models. 
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4.2 Traceability and authentication study along the production 
chain of hazelnut paste by elemental profiling 
We applied elemental and REEs profiling through Inductively Coupled Plasma – 
Mass Spectrometry (ICP-MS) and ICP – Optical Emission Spectroscopy (OES) in 
an authentication study involving the production chain of hazelnut paste: from raw 
fruits, to roasted hazelnuts, down to the final paste. The study involves three different 
cultivars (“Tonda Gentile delle Langhe”, “Romana” and “Mortarella”) and the data 
were treated by multivariate statistical classification methods to provide a model able 
to discriminate the three cultivars independently from the type of technological 
transformation.  
 
4.2.1 Materials and methods 
4.2.1.1 Reagents  
Nitric Acid 69% Trace Select and hydrogen peroxide H2O2 30% Trace Select were 
purchased from Fluka Analytical (Buchs, Switzerland); multielemental standard 
Solutions CCS1, CCS2, CCS4, CCS5, CCS6, for the calibration of the ICP-MS and 
ICP-OES, were purchased from Inorganic Ventures (Christiansburg, VA, USA). 
Ultrapure water was obtained through a Millipore Milli-Q system (Milford, USA).  
 
4.2.1.2 Samples  
Hazelnut samples were bought directly from local producers. Samples belong to 
three different cultivars: “Tonda Gentile delle Langhe”, “Romana” and “Mortarella”. 
For each cultivar, three to four different batches were available, each corresponding 
to a different production lot either from the same producer or from a different one, 
located in the same geographical area. For each cultivar, the production chain 
involved: raw hazelnuts, roasted hazelnuts and paste. The same production lots were 
available both as raw and roasted, while not all the production lots were available as 
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a paste. For each final sample (cultivar/type of product/lot), at least three analytical 
replications (from the mineralization step to the final instrumental determinations) 
were performed. Each cultivar was therefore characterized by 3-4 lots, each 
replicated 3-4 times and present as raw, roasted or paste samples. The samples 
available were therefore 119: 31 samples from “Romana” cultivar (12 raw, 12 
roasted, 7 paste), 47 samples from “Mortarella” cultivar (16 raw, 15 roasted, 16 
paste) and 41 samples from “Tonda Gentile delle Langhe” cultivar (14 raw, 14 
roasted, 13 paste). 
Each sample was characterized by a four-digit label: a letter indicating the cultivar 
(M for “Mortarella”, P for “Tonda Gentile delle Langhe”, R for “Romana”) followed 
by a number indicating the lot (1 to 4), a letter indicating the type of samples (C for 
raw hazelnuts, T for roasted hazelnuts and P for paste) and a final progressive number 
indicating the analytical replication.     
 
4.2.1.3 Sample digestion 
Samples were first grinded in a mortar and put in a stove for at least 12h at 105°C 
until constant weight was achieved. Elemental analysis was carried out after 
microwave-assisted digestion using a microwave oven MDS 2000 (CEM 
Corporation, Matthews, NC, USA). 0.5000 g of sample (raw or roasted hazelnuts or 
hazelnut paste) were put in a Teflon vessel (CEM Corporation, Matthews, NC, USA) 
and added with 5 mL of nitric acid 69%. A first mineralization step in the microwave 
oven was accomplished at 630 W, with the following pressure gradient: 20 psi in 15 
min with 5 min of rest time, 40 psi in 15 min with 5 min of rest time, 85 psi in 15 
min with 5 min of rest time, 150 psi in 15 min with 5 min of rest time, 200 psi in 15 
min with 5 min of rest time. Then 1 mL of H2O2 30% was added and a second 
mineralization step took place in the microwave oven, at 630W with a pressure 
gradient achieving a final pressure of 100 psi in 15 min with 5 min of rest time.  
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After mineralization, the solution was diluted to 50 mL with ultrapure water and 
further diluted 1:10 v/v with nitric acid 1% for ICP-MS analysis and 1:5 v/v with 
nitric acid 1% for ICP-OES analysis. 
 
4.2.1.4 ICP-MS analysis 
For the determination of metals and rare earths (45Sc, 51V, 52Cr, 55Mn, 56Fe, 
59Co, 60Ni, 63Cu, 65Cu, 66Zn, 71Ga, 75As, 78Se, 88Sr, 89Y, 107Ag, 111Cd, 
120Sn, 138Ba, 139La, 140Ce, 141Pr, 146Nd, 147Sm, 153Eu, 158Gd, 159Tb, 
163Dy, 165Ho, 166Er, 169Tm, 172Yb, 175Lu, 187Re, 193Ir, 206Pb, 207Pb, 208Pb, 
232Th, 238U) an inductively coupled plasma with mass spectrometry (ICP-MS 
7700X Agilent) was used. The instrumental signal acquisition parameters are: 
reported in table 1.  
 
Parameter Value 
Number of Points per Mass: 3 
Number of repetitions 3 
Total Acquisition Time 653 sec 
Set Peristaltic Pump Program:  
Before Acquisition:  
Uptake speed: 0.40 rps 
Uptake time: 45 sec 
Stabilization time: 35 sec 
After acquisition (Probe Rinse):  
Rinse speed: 10-2 rps 
Rinse on rinse port (sample) 5 sec 
Rinse on rinse port (STD) 5 sec 
After Acquisition (Rinse)  
Rinse vial1 2 
Rinse speed 0.30 rps 
Rinse on rinse vial (step 1): 30 sec 
Rinse on rinse port (Step 1): 0 sec 
Table 1: ICP-MS experimental settings.  
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Each calibration curve was calculated by means of the following 7 standard 
solutions: 0.000100 gL-1, 0.00100 gL-1, 0.0100 gL-1, 0.100 gL-1, 1.00 gL-1, 
10.0 gL-1, 100 gL-1, covering a concentration range of 7 orders of magnitude. A 
weighted least square fitting was used, weighting the errors by the inverse of the 
concentration level. Table 2  reports the LOD and LOQ for each investigated isotope, 
determined by the calibration curve method (72,73).  
 
  LOD LOQ    LOD LOQ 
45Sc 0.011 0.030  140Ce 0.00024 0.00082 
51V 0.0039 0.0053  141Pr 0.00038 0.00020 
52Cr 0.011 0.031  146Nd 0.0011 0.00097 
55Mn 0.0040 0.065  147Sm 0.0010 0.00069 
56Fe 0.085 0.15  153Eu 0.00034 0.00010 
59Co 0,00081 0.0042  158Gd 0.00033 0.00052 
60Ni 0.016 0.094  159Tb 0.0011 0.0064 
63Cu 0.38 0.67  163Dy 0.00067 0.00013 
65Cu 0.56 0.68  165Ho 0.0010 0.0066 
66Zn 0.77 2.76  166Er 0.00020 0.00014 
71Ga 0.0037 0.0057  169Tm 0.00023 0.000076 
75As 0.014 0.010  172Yb 0.00083 0.00042 
78Se 0,35 0.80  175Lu 0.00020 0.00015 
88Sr 0.0078 0.049  187Re 0.0014 0.0063 
89Y 0.0037 0.0095  193Ir 0.00013 0.00043 
107Ag 0.019 0.038  206Pb 0.011 0.14 
111Cd 0.0039 0.0078  207Pb 0.028 0.14 
120Sn 0.0044 0.041  208Pb 0.0044 0.13 
138Ba 0.0080 0.092  232Th 0.00024 0.00022 
139La 0.00096 0.00071  238U 0.00034 0.00026 
Table 2: LOD and LOQ values for all isotopes expressed in gL-1 
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4.2.1.5 ICP-OES analysis 
Majority elements (Ca, Fe, Mg, Na, P, S, Si, Al) were determined by a Spectro 
Genesis inductively coupled plasma with optical emission (ICP-OES) (Spectro 
Genesisi Ametek – Berwyn, PA, USA) equipped with a cross-flow nebulizer, a 
double-pass Scott spray chamber and an ASX-260 autosampler (CETAC 
Technologies – Omaha, NE, USA). Signals were elaborated by Spectro Smart 
Analyzer Vision software (ver. 5.06). Plasma worked at the power of 1400 W; 
coolant, auxiliary and nebulizer flow rates were set at 12.00, 1.00 and 1.00 L/min 
respectively. Peristaltic pump run at 2 (on a scale from 1 to 5), except for preflush 
which was set at 4. Results were given as average value of three instrumental 
replications. For each analyte, the following wavelengths were used for 
quantification: 317.933 nm (Ca), 259.941 nm (Fe), 279.553 nm (Mg), 588.995 nm 
(Na), 214.914 nm (P), 182.034 nm (S), 251.612 nm (Si), 396.152 nm (Al). Each 
calibration curve was calculated by means of the following 5 standard solutions: 
0.0100 mgL-1; 0.0500 mgL-1; 0.100 mgL-1; 0.500 mgL-1; 1.00 mgL-1; 5.00 mgL-1. As 
for ICP-MS analysis, a weighted least square fitting was used. LOD and LOQ for 
each investigated analyte (72,73) are reported in Table 3. 
 
Element LOD LOQ 
Ca 0.016 0.024 
Fe 0.0048 0.0072 
Mg 0.011 0.017 
Na 0.045 0.067 
P 0.012 0.018 
S 0.027 0.040 
Si 0.0088 0.013 
Al 0.0057 0.0086 
Table 3: LOD and LOQ values for all isotopes expressed in mgL-1
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4.2.1.6 Software 
Data analysis and all graphical representations were performed by The Unscrambler 
X 10.3 (Camo, Norway), Statistica v.7.1 (StatSoft Inc, Tulsa, OK, USA), Matlab 
R2014b (The Mathworks, Natick, MA, USA), the Classification Toolbox for Matlab 
(Milano Chemometrics group, University of Milano Bicocca, Italy) (53), Parvus 
(Prof Michele Forina, University of Genova, Italy) and Excel 2013 (Microsoft 
Corporation, Redmond, WA, USA).  
 
4.2.2 Results and Discussion 
Table 4 reports the concentration levels, expressed as g/kg of product, of each 
analyte within each cultivar and each type of product separately, together to the 
corresponding standard deviation.  
  Mortarella 
  Raw Roasted Paste 
45Sc (6.6 ± 2.1)100 (7.4 ± 2.0)100 (8.0 ± 2.5)100 
51V (1.28 ± 0.28 )101   (9.5 ± 3.2)100 (1.9 ± 1.2)101 
52Cr (3.5 ± 1.9 )102 (3.2 ± 2.4)102 (5.5 ± 4.7)102 
55Mn (6.9 ± 3.3)104 (1.09 ± 0.81)105 (7.9 ± 2.2)104 
56Fe (9.3 ± 1.6)104 (9.3 ± 1.1)104 (9.2 ± 1.7)104 
59Co (1.7 ± 1.2)102 (1.29 ± 0.60)102 (2.09 ± 0.89)102 
60Ni (1.03 ± 0.24)103 (9.9 ± 4.9)102 (1.67 ± 0.86)103 
63Cu (3.4 ± 0.80)104  (3.48 ± 0.58)104 (3.63 ± 0.48)104 
65Cu (3.36 ± 0.94)104 (3.49 ± 0.59)104 (3.63 ± 0.51)104 
66Zn (3.6 ± 0.57)104 (3.69 ± 0.48)104 (3.54 ± 0.42)104 
71Ga (3.5 ± 1.1)100 (3.4 ± 1.4)100 (4.9 ± 2.2)100 
75As (4.75 ± 0.88)101 (4.41 ± 0.91)101 (5.8 ± 1.4)101 
78Se (2.7 ± 1.5)102 (2.6 ± 1.7)102 (2.6 ± 1.6)102 
88Sr (4.1 ± 1.6)104 (5.5 ± 3.4)104 (4.0 ± 1.3)104 
89Y (4.7 ± 1.7)100 (5.9 ± 4.0)100 (7.2 ± 3.0)100 
107Ag (5.3 ± 4.2)101 (4.9 ± 5.1)101 (6.5 ± 6.9)101 
111Cd (1.83 ± 0.53)101 (2.6 ± 1.4)101 (1.81 ± 0.41)101 
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120Sn (3.9 ± 1.8)101 (3.5 ± 2.0)101 (1.14 ± 0.91)102 
138Ba (1.70 ± 0.78)104 (2.1 ± 1.2)104 (1.74 ± 0.63)104 
139La (7.6 ± 2.3)100 (7.2 ± 5.5)100 (9.9 ± 8.2)100 
140Ce (9.6 ± 2.8)100 (6.6 ± 3.4)100 (1.6 ± 1.3)101 
141Pr (1.07 ± 0.30)100 (7.9 ± 3.7)10-1 (1.8 ± 1.6)100 
146Nd (4.9 ± 1.4)100 (3.7 ± 1.8)100 (7.6 ± 6.4)100 
147Sm (9.8 ± 2.6)10-1 (8.6 ± 3.6)10-1 (1.5 ± 1.1)100 
153Eu (5.8 ± 2.5)100 (7.5 ± 4.1)100 (6.1 ± 2.0)100 
158Gd (9.5 ± 2.5)10-1 (7.6 ± 3.7)10-1 (1.4 ± 1.1)100 
159Tb (5.6 ± 3.2)10-1 (7.7 ± 3.6)10-1 (1.12 ± 0.61)100 
163Dy (6.1 ± 1.4)10-1 (5.9 ± 2.9)10-1 (8.1 ± 5.0)10-1 
165Ho (4.8 ± 2.8)10-1 (7.1 ± 3.7)10-1 (9.7 ± 5.9)10-1 
166Er (2.68 ± 0.70)10-1 (2.7 ± 1.5)10-1 (3.6 ± 2.1)10-1 
169Tm (4.7 ± 2.4)10-2 (3.7 ± 2.2)10-2 (5.6 ± 3.3)10-2 
172Yb (2.97 ± 0.85)10-1 (2.4 ± 1.2)10-1 (3.8 ± 2.3)10-1 
175Lu (4.8 ± 2.4)10-2 (5.3 ± 2.7)10-2 (7.0 ± 3.8)10-2 
187Re (4.6 ± 2.9)10-1 (7.3 ± 4.8)10-1 (1.04 ± 0.61)100 
193Ir (1.14 ± 0.99)10-1 (10.0 ± 6.0)10-2 (8.2 ± 3.4)10-2 
206Pb (1.4 ± 2.8)102 (7.0 ± 5.3)101 (1.49 ± 0.70)102 
207Pb (1.3 ± 2.7)102 (6.5 ± 4.9)101 (1.38 ± 0.65)102 
208Pb (1.2 ± 2.4)102 (5.9 ± 4.4)101 (1.25 ± 0.59)102 
232Th (1.66 ± 0.55)100 (1.16 ± 0.79)100 (3.3 ± 3.5)100 
238U (1.32 ± 0.93)100 (1.18 ± 0.95)100 (2.3 ± 1.2)100 
Ca (1.49 ± 0.29)106 (1.47 ± 0.29)106 (1.32 ± 0.19)106 
Fe (4.49 ± 0.63)104 (4.41 ± 0.31)104 (4.16 ± 0.80)104 
Mg (1.670 ± 0.094)106 (1.65 ± 0.12)106 (1.48 ± 0.13)106 
Na (1.75 ± 0.72)104 (1.67 ± 0.95)104 (2.19 ± 0.50)104 
P (2.15 ± 0.24)106 (2.01 ± 0.12)106 (1.97 ± 0.20)106 
S (1.66 ± 0.11)106 (1.66 ± 0.16)106 (1.45 ± 0.14)106 
Si (1.20 ± 0.55)104 (1.23 ± 0.84)104 (1.08 ± 0.51)104 
Al (5.2 ± 2.2)103 (3.6 ± 1.5)103 (6.7 ± 3.6)103 
 
  Piemonte IGP 
  Raw Roasted Paste 
45Sc (6.3 ± 1.4 )100 (5.7 ± 3.9 )100 (6.5 ± 1.5)100  
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51V (1.31 ± 0.28 )101 (3.50 ± 10.1)101 (1.10 ± 0.54 )101 
52Cr (3.1 ± 2.2)102 (3.4 ± 2.8)102  (9.5 ± 9.3)102 
55Mn (5.3 ± 1.6)104 (7.8 ± 4.6)104  (5.0 ± 1.7)104 
56Fe (7.0 ± 1.0)104 (5.9 ± 1.4)104  (6.5 ± 2.0)104 
59Co (1.15 ± 0.32)102  (2.9 ± 1.7)102  (1.48 ± 0.52)102 
60Ni (4.8 ± 1.2 )103  (5.9 ± 1.6)103  (3.7 ± 1.4)103  
63Cu (2.95 ± 0.86)104  (2.89 ± 0.62)104  (2.70 ± 0.58)104 
65Cu (2.8 ± 1.0)104  (2.83 ± 0.71)104  (2.63 ± 0.71)104 
66Zn (3.0 ± 1.1)104 (3.05 ± 0.51)104  (2.61 ± 0.56)104 
71Ga (3.8 ± 1.2)100 (3.33 ± 0.79)100  (3.17 ± 0.79)100 
75As (3.9 ± 1.2)101 (4.1 ± 2.1)101  (3.79 ± 0.68)101 
78Se (2.8 ± 1.1)102 (2.6 ± 1.5)102  (3.4 ± 3.1)102  
88Sr (1.19 ± 0.14)104 (1.18 ± 0.27)104 (1.45 ± 0.61)104 
89Y (5.2 ± 1.0)100  (3.2 ± 1.0)100  (4.1 ± 1.1)100  
107Ag (4.3 ± 2.8)101  (5.8 ± 4.1)101  (5.6 ± 4.9)101  
111Cd (1.68 ± 0.93 )101 (3.4 ± 2.5)101  (1.46 ± 0.87)101 
120Sn (5.7 ± 6.7)101  (3.8 ± 2.5)101  (5.4 ± 5.2)101  
138Ba (5.7 ± 2.8)103  (7.0 ± 2.6 )103 (7.9 ± 3.9)103  
139La (5.8 ± 2.9)100  (2.94 ± 0.66)100 (3.6 ± 1.1)100  
140Ce (9.8 ± 5.0)100  (4.6 ± 1.8)100  (5.9 ± 1.6)100  
141Pr (1.10 ± 0.54)100  (5.0 ± 2.0)10-1 (6.0 ± 1.5)10-1 
146Nd (5.4 ± 2.6)100  (2.6 ± 1.1)100  (2.94 ± 0.74)100 
147Sm (1.18 ± 0.50)100 (6.7 ± 2.6)10-1 (6.6 ± 2.1)10-1  
153Eu (2.11 ± 0.97)100 (2.46 ± 0.84)100 (2.7 ± 1.2)100  
158Gd (1.17 ± 0.50)100  (6.1 ± 2.7)10-1  (7.1 ± 1.6)10-1 
159Tb (5.5 ± 3.2)10-1  (2.6 ± 3.5)10-1  (6.8 ± 2.6)10-1 
163Dy (7.8 ± 2.3)10-1  (4.5 ± 1.3)10-1  (4.6 ± 1.2)10-1 
165Ho (4.4 ± 2.6)10-1  (2.2 ± 3.0)10-1  (5.6 ± 2.3)10-1 
166Er (3.23 ± 0.80)10-1 (2.12 ± 0.62)10-1 (2.01 ± 0.43)10-1 
169Tm (4.6 ± 2.1)10-2  (2.76 ± 0.73)10-2 (2.6 ± 1.0)10-2  
172Yb (3.3 ± 1.0)10-1  (1.91 ± 0.67)10-1 (2.05 ± 0.62)10-1 
175Lu (5.2 ± 2.4)10-2 (2.5 ± 1.4)10-2  (3.37 ± 0.90)10-2 
187Re (3.5 ± 2.0)10-1 (2.1 ± 2.9)10-1  (5.2 ± 2.6)10-1  
193Ir (6.0 ± 2.9)10-2 (6.2 ± 5.9)10-2  (7.0 ± 4.3)10-2  
206Pb (1.5 ± 1.0)102  (1.3 ± 1.4)102  (1.22 ± 0.90)102 
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207Pb (1.40 ± 0.97)102 (1.2 ± 1.4)102  (1.13 ± 0.87)102 
208Pb (1.27 ± 0.87)102 (1.1 ± 1.2)102  (1.02 ± 0.78)102 
232Th (1.36 ± 0.58)100 (8.0 ± 3.4)10-1 (8.2 ± 2.5)10-1  
238U (1.20 ± 0.76)100 (8.3 ± 3.4)10-1 (1.20 ± 0.66)100 
Ca (1.32 ± 0.17)106 (1.26 ± 0.18)106 (1.08 ± 0.20)106 
Fe (3.45 ± 0.48)104 (2.98 ± 0.60)104 (3.07 ± 0.86)104 
Mg (1.63 ± 0.16)106 (1.71 ± 0.12)106 (1.31 ± 0.24)106 
Na (2.12 ± 0.78)104 (2.09 ± 0.59)104 (1.76 ± 0.63)104 
P (2.17 ± 0.30)106 (2.41 ± 0.19)106 (1.72 ± 0.34)106 
S (1.63 ± 0.21)106 (1.57 ± 0.11)106 (1.24 ± 0.24)106 
Si (1.64 ± 0.54)104 (1.16 ± 0.33)104 (1.26 ± 0.57)104 
Al (5.7 ± 1.8)103 (4.4 ± 2.0)103 (4.5 ± 1.2)103  
  Romana 
  Raw Roasted Paste 
45Sc (7.3 ± 4.4)100  (6.8 ± 2.4)100  (4.6 ± 2.4)100  
51V (1.54 ± 0.38)101  (1.33 ± 0.76)101  (8.0 ± 4.1)100  
52Cr (4.2 ± 2.5)102  (3.8 ± 2.2)102  (3.7 ± 5.1)102  
55Mn (1.13 ± 0.15)100  (8.3 ± 2.0)104  (8.4 ± 4.2)104  
56Fe (9.5 ± 1.2)104  (9.7 ± 1.6)104  (6.7 ± 3.1)104  
59Co (3.7 ± 1.7)102  (2.73 ± 0.98)102  (1.69 ± 0.94)102  
60Ni (1.42 ± 0.65)103  (1.37 ± 0.85)103  (1.11 ± 0.61)103  
63Cu (4.04 ± 0.59)104  (3.62 ± 0.96)104  (2.7 ± 1.3)104  
65Cu (4.07 ± 0.58)104  (3.65 ± 0.97)104  (2.6 ± 1.3)104  
66Zn (3.71 ± 0.61)104  (4.4 ± 1.7)104  (2.8 ± 1.3)104  
71Ga (5.2 ± 1.3)100  (3.62 ± 0.90)100  (2.9 ± 1.7)100  
75As (9.1 ± 7.2)101  (7.4 ± 3.4)101  (4.6 ± 1.8)101  
78Se (2.9 ± 1.3)102  (1.98 ± 0.96)102  (1.17 ± 0.48)102  
88Sr (7.7 ± 2.6)104  (1.06 ± 0.23)105  (5.9 ± 2.9)104  
89Y (7.9 ± 2.1)100  (6.6 ± 2.1)100  (5.4 ± 1.5)100  
107Ag (6.2 ± 3.1)101  (3.7 ± 2.3)101  (2.0 ± 1.8)101  
111Cd (1.84 ± 0.64)101  (1.92 ± 0.79)101  (1.33 ± 0.62)101  
120Sn (9.0 ± 11.1)101  (6.3 ± 3.0)101  (3.6 ± 4.2)101  
138Ba (3.1 ± 1.7)104  (3.8 ± 1.9)104  (2.9 ± 1.6)104  
139La (1.50 ± 0.32)101  (1.9 ± 3.2)101  (5.3 ± 2.6)100  
140Ce (1.98 ± 0.35)101  (1.20 ± 0.57)101  (7.0 ± 3.6)100  
122 
 
141Pr (2.30 ± 0.62)100  (1.46 ± 0.69)100  (8.3 ± 4.4)10-1 
146Nd (9.6 ± 1.8)100  (6.5 ± 3.1)100  (3.8 ± 2.0)100  
147Sm (2.06 ± 0.74)100  (1.53 ± 0.77)100  (8.8 ± 4.8)10-1 
153Eu (1.07 ± 0.53)101  (1.24 ± 0.53)101  (9.2 ± 5.4)100  
158Gd (1.92 ± 0.67)100  (1.30 ± 0.56)100  (8.1 ± 4.0)10-1 
159Tb (8.09 ± 8.09)10-1  (5.7 ± 3.3)10-1  (8.8 ± 9.6)10-1 
163Dy (1.11 ± 0.57)100  (8.1 ± 3.1)10-1  (5.6 ± 2.8)10-1 
165Ho (7.5 ± 8.5)10-1  (5.2 ± 3.0)10-1  (7.9 ± 9.2)10-1 
166Er (5.6 ± 4.3)10-1  (3.7 ± 1.8)10-1  (2.3 ± 1.2)10-1 
169Tm (1.9 ± 4.1)10-1  (8.18 ± 0.11)10-2  (3.1 ± 2.0)10-2 
172Yb (5.9 ± 5.3)10-1  (3.7 ± 2.1)10-1  (2.3 ± 1.1)10-1 
175Lu (1.8 ± 4.0)10-1  (8.51 ± 0.13)10-2  (3.4 ± 2.3)10-2 
187Re (7.1 ± 9.4)10-1  (4.3 ± 3.5)10-1  (7.1 ± 8.7)10-1 
193Ir (2.3 ± 3.7)10-1  (1.6 ± 2.0)10-1  (6.9 ± 5.0)10-2 
206Pb (9.6 ± 6.3)101  (1.18 ± 0.95)102  (1.10 ± 0.84)102  
207Pb (9.2 ± 6.1)101  (1.12 ± 0.89)102  (1.01 ± 0.78)102  
208Pb (8.2 ± 5.5)101  (1.01 ± 0.80)102  (9.2 ± 7.1)101  
232Th (4.60 ± 0.82)100  (2.9 ± 1.9)100  (1.38 ± 0.73)100  
238U (3.4 ± 1.8)100  (3.8 ± 3.6)100  (1.1 ± 0.75)100  
Ca (1.34 ± 0.18)106  (1.77 ± 0.40)106  (1.50 ± 0.22)106  
Fe (4.60 ± 0.40)104  (5.04 ± 0.82)104  (4.0 ± 0.61)104  
Mg (1.79 ± 0.12)106  (1.95 ± 0.21)106  (1.57 ± 0.18)106 
Na (1.44 ± 0.98)104  (1.41 ± 0.82)104  (2.23 ± 0.48)104 
P (2.40 ± 0.28)106  (2.55 ± 0.33)106  (2.00 ± 0.28)106 
S (1.76 ± 0.12)106  (2.02 ± 0.24)106  (1.61 ± 0.18)106 
Si (1.85 ± 0.70)104  (1.48 ± 0.61)104  (1.11 ± 0.42)104 
Al (5.9 ± 1.3)103  (4.9 ± 2.5)103  (4.0 ± 2.0)103  
Table 4: the concentration levels expressed as g/kg of product together to the corresponding 
standard deviation 
 
The analytes can be ideally divided into three groups:  
- majority elements (Ca, Mg, P, S), with concentration levels in the range of 
g/kg; 
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- trace elements (Fe, Na, Si, Al, Ni, Cu, Zn, Sr, Ba), with concentration levels 
in the range of ppm; 
- micro-trace elements (V, Cr, Co, As, Se, Ag, Cd, La, Ce, Eu, Pb), with 
concentration levels in the range of ppb; 
- ultra-trace elements (Sc, Mn, Ga, Y, Sn, Pr, Nd, Sm, Gd, Dy, Re, Ir, Th, U), 
with concentrations levels in the range of ppt. 
Looking at the raw data, it is not possible to identify elements with an increasing or 
decreasing trend along the production chain (raw / roasted / paste), considering the 
great variability of the data collected. Similarly, differences in the concentration 
levels of single elements cannot be identified by a direct comparison of the 
concentration levels of the different cultivars.  
4.2.2.1 Principal Component Analysis (PCA) 
Since in principle, the absolute concentration level of the analytes could vary along 
the production chain in the order: raw > roasted > paste, the absolute concentration 
levels are not a good choice for describing the data. Data were therefore scaled for 
each analyte independently since each analyte could be used as a normalizing factor. 
(as described in section 1.1.3.1) 
The final dataset has therefore size 119 x 2068 (119 being the number of samples 
and 2068 being the number of ratios of each analyte with respect to all the others) 
(159Tb, 165Ho, 187Re and 193Ir were eliminated as normalizing factors since some null 
values were present). 
A first PCA carried out on the dataset, after autoscaling, showed that a slight 
differentiation of the samples according to the type of product is present 
notwithstanding the predominance of the information about the cultivar. In order to 
remove this source of confounding information, data were first centered with respect 
to the mean of each type of product (raw, roasted or paste), and then autoscaled 
(mean-centered and normalized to unit variance). 
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Figure 1 reports the score plot of the first two PCs that account for about 28% of the 
overall variance contained in the dataset (respectively PC1=17%, PC2=11%, 
PC3=8%, PC4=7%). Figure 1 reports two representations of the same score plot: one 
where the samples are labelled according to the different cultivar (figure 1a) and the 
other with a labelling related to the type of sample (figure 1b): the score plot reports 
a quite clear separation of the samples according to the cultivar along the first PC, 
with R samples at negative values along PC1, P samples at positive values and M 
samples at intermediate levels. The same plot shows no differentiation of the samples 
according to the different type of sample investigated.  
 
 
 
(1a) 
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Figure 1: results of PCA carried out on the overall dataset. Score plot of the first two PCs labelling 
the samples according to the cultivar (a) and to the type of product (b).   
 
4.2.2.2 Partial-Least-Squares Discriminant Analysis (PLS-DA) 
Classification tools were then applied to identify the variables responsible for the 
differences between the cultivars, independently from the technological treatment 
that hazelnut samples underwent. To this purpose, PLS-DA was applied with an 
iterative variable selection procedure in backward elimination: at each iteration, the 
variables with the least classification ability are eliminated according to the minor 
error in cross-validation; the excluded variables are characterized by the smallest 
importance (55) and no more than 3% of the variables is eliminated at each iteration. 
Cross-validation was accomplished by a leave-more-out (LMO) procedure with 5 
cancellation groups, eliminating at each cycle all the replications of the same sample 
in order to make the validation more genuine. Three PLS-DA models were obtained, 
each discriminating one class from the others. The final model was obtained by 
(1b) 
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merging the variables selected by the three independent models and contained 421 
variables. The best performance was obtained with a final model containing five LVs 
(table 5), explaining 49% of the information about class belonging and 85% of the 
elemental profile.  
 
 
X Y X Y 
 
% Expl. 
Var. 
Fitting 
% Expl. 
Var. 
CV 
% Expl. 
Var. 
Fitting 
% Expl. 
Var. 
CV 
% Cum. 
Expl. 
Var. 
Fitting 
% Cum. 
Expl. 
Var. 
CV 
% Cum. 
Expl. 
Var. 
Fitting 
% Cum. 
Expl. 
Var. 
CV 
LV1 41.03 40.46 22.64 20.74 41.03 40.46 22.64 20.74 
LV2 35.66 32.50 7.06 5.70 76.69 72.96 29.70 26.44 
LV3 4.85 4.66 7.23 6.74 81.54 77.62 36.93 33.18 
LV4 3.35 1.93 4.90 4.21 84.89 79.55 41.83 37.40 
LV5 0.90 1.10 8.04 5.79 85.79 80.65 49.87 43.19 
LV6 1.47 -0.78 2.48 3.40 87.26 79.87 52.35 46.59 
LV7 2.00 -0.99 1.71 2.56 89.25 78.87 54.06 49.15 
LV8 0.87 0.06 3.91 2.28 90.13 78.93 57.97 51.43 
LV9 0.79 0.00 3.82 2.15 90.92 78.93 61.79 53.58 
LV10 0.76 0.26 2.54 2.01 91.67 79.19 64.34 55.59 
Table 5: Percentage of explained and cumulative explained variance for the first ten LVs calculated.  
Figure 2a shows the score plot of the first three LVs, the three classes being 
represented with different marks (M with full black circles, P with empty circles and 
R with full gray circles): the three classes appear well separated along the first three 
LVs calculated. LV1 is mostly responsible for the differences between P samples (at 
negative scores) and the other two cultivars (at positive scores), while the differences 
between P and R on one side and M samples on the other side are mainly described 
by the second LV (P and R at negative or slightly positive scores and r samples at 
positive scores). The third one mainly separates P and M cultivars from R (P and M 
at positive scores and R at negative ones).  
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Figure 2: results of PLS-DA with variable selection. Score plot of the first three LVs calculated. 
Samples are labelled according to the cultivar. 
 
The classification performance in cross-validation was calculated for the final model 
by a leave-more-out procedure with 1000 iterations, eliminating at each iteration the  
20% of the samples of each class, randomly selected. The final model shows a very 
good classification performance both in fitting and cross-validation, with an NER% 
of 100% in fitting and 96.95% in cross-validation and an accuracy of 100% in fitting 
and 96.72% in cross-validation.  
The values calculated for sensitivity, precision and specificity (table 3) are very good 
both in fitting (precision, sensitivity and specificity always equal to 100%) and in 
cross-validation (precision always > 96.1%, sensitivity > 94.8% and specificity > 
97.9%).  
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The information about the discriminating variables is contained in the regression 
coefficients: since three classes are present, three sets of regression coefficients can 
be calculated, one for each cultivar. To clarify the identification of the potential 
markers of authentication, a dendrogram was built on these coefficients (Ward 
method; distance calculated by the Pearson’s correlation index) considering all the 
three classes (figure 3).  
 
 
Figure 3: Dendrogram of the regression coefficients (Ward method; Pearson’s r-coefficient). The 
variables are on the y-axis and the distance% on the x-axis. The vertical cut applied in the 
dendrogram identifies two groups of variables, further separated in five total groups.  
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This representation reports the variables on the y-axis and the distance at which the 
groups are merged together (scaled to the maximum distance) on the x-axis and it is 
useful to identify groups of variables with similar behavior. The dendrogram 
represents the variables along the y-axis, all separated (each one represents a 
different group); they are progressively merged in groups from left to right (where 
all the variables merge in a unique group). Groups can be identified by operating 
vertical cuts of the diagram and individuating the number of horizontal lines 
encountered. The dendrogram reported in figure 3, first identifies two main groups 
of variables (A and B) operating a cut at a distance level of 50%. These groups can 
be further separated into five sub-groups operating a cut at a distance level of 5%: 
three sub-groups of A (A1, A2 and A3) and two sub-groups of B (B1 and B2). Figure 
4 reports the regression coefficients (Y-axis) calculated for each selected variable (x-
axis) for each class (cultivar) independently: to make the discussion clearer, the 
entire representation was separated into different panels according to the group to 
which the variables belong in the dendrogram. In general, positive coefficients for a 
specific cultivar indicate variables (ratios) with a larger value for that cultivar, while 
negative coefficients show an opposite behavior.  
Group A1 (Figure 4a) was separated in two panels for a clearer evaluation of the 
markers included in the group (x-axis): looking at the values of the coefficients for 
the three cultivars, it can be noticed that the markers belonging to this group allow 
to discriminate M from R samples (markers with large values for M samples and 
small values for R samples; P samples show intermediate values).  
Group A2 (Figure 4b) contains markers that allow the differentiation between M 
samples and the other two (larger values for M samples and small in both P and R 
samples). 
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Group A3 (Figure 4c) contains markers differentiating P from M cultivars (includes 
variables with large values in P samples and small in M samples; R samples show 
intermediate values). 
Group B1 (Figure 4 d) contains markers that discriminate M from the ther two 
cultivars but with an opposite behavior with respect to group A2: these variables 
show large values for P and R samples and small ones for M samples. 
Group B2 (Fig 4 e) contains markers for the differences between R and M cultivars 
(includes variables with large values in R samples and small in M samples, P samples 
showing intermediate values). This group shows a behavior opposite to group A1.  
Analyzing the variables present in the five groups, it is possible to say that:  
• In Group A1, the most frequent elements are Ga, Al and Sc, in terms of ratios 
in which these elements are at the numerator. For what regards the 
normalizing factors, those most present in this group are Cr, Th, As and Co. 
• Similarly, group A2 contains several ratios with a contribution (at the 
numerator) of Fe, Cu, Ag, Re and Mn. The most frequent normalizing factors 
are instead Pb, Ni, Gd, P, S and Dy. 
• Group A3 shows a great contribution of Gd, Pb, Ni, Se and Ca (at the 
numerator), while the most frequent normalizing factors are Ba, La and Sr. 
• Group B1 contains ratios with a large contribution of Cr, As and Ba, but also, 
at a smaller extent S, Gd, P and Eu. For what regards the normalizing factors, 
the most frequent are Cd, V and Na. 
• Group B2 contains several rations with a contribution of Ba, Eu, Co and Sr, 
while the most present normalizing factors are Sc, Cu, Zn, Ga and Na. 
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Figure 4a: A1: Mortarelle vs Romane 
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Figure 4b: A2: Mortarelle vs Romane/Piemonte 
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Figure 4c: A3: Piemonte vs Mortarelle 
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Figure 4e: B2: Mortarelle vs Romane 
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Figure 4(a, b, c, d, e): Regression coefficients (reported on the y-axes) of each selected original 
variable (x-axes), labelled independently for each cultivar: regression coefficients were calculated 
on the final model containing three LVs. The overall representation is split in six panels 
corresponding to the groups identified in the dendrogram. Group A1 was split in two parts to make 
it more readable.  
 
4.2.3 Conclusion  
Here, a model for the authentication of the hazelnut cultivar along the production 
chain of hazelnut paste was built, based on the elemental profile of the samples. The 
work involved three different cultivars: "Mortarella", "Tonda Gentile delle Langhe" 
and "Romana". The 119 available samples were mineralized by microwave assisted 
digestion and the elemental profile was determined by ICP-OES and ICP-MS. 
Data were normalized for each element separately and then the data were centered 
with respect to each type of product independently (raw hazelnuts, toasted hazelnuts 
or paste). 
The procedure based on the calculation of elemental ratios based on different 
normalizing factors proved to be a good choice, since the discriminating variables 
identified by PLS-DA include variables normalized by different normalizing factors 
with a quite different behavior as markers of authenticity, as highlighted by the 
analysis of the regression coefficients. In fact, the five groups of identified markers 
are characterized by both different elements and different normalizing factors. The 
results obtained show that authentication of hazelnuts along the production chain of 
hazelnuts paste, passing from raw to roasted fruits and then producing the 
corresponding paste, is possible with a good accuracy, based on the elemental 
profiling of both major elements and trace and ultra-trace elements.   
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4.3 Authentication of hazelnut cultivars by FTIR spectroscopy 
The second study was carried out to investigate whether FTIR spectroscopy could 
be applied for a fast authentication of hazelnut cultivars. Infrared spectra were 
therefore collected on raw hazelnuts from three different cultivars (“Tonda gentile 
delle Langhe” from Piedmont, “Mortarella” from Campania and “Tonda gentile 
Romana” from Latium); the spectra were processed with different pre-treatment 
methods (baseline, first and second derivative, multiplicative scatter correction, 
standard normal variate) and coupled to different multivariate statistical methods in 
order to find the best classification model able to discriminate the samples according 
to their cultivar. PCA-LDA and PLS-DA, with and without the application of a 
variable selection algorithm, were employed to classify the hazelnut samples from 
different cultivars (18). 
 
4.3.1 Materials and Methods 
4.3.1.1 Samples 2.1 
A total of 60 raw hazelnut samples from different geographical origins/cultivars were 
employed. The samples were from three different Italian regions and correspond to 
three different cultivars: “Tonda gentile delle Langhe” (TGL; from Piedmont), 
“Mortarella” (Campania) and “Tonda gentile Romana” (TGR, from Latium); the 
hazelnuts were shelled and preserved in a cold room before the analysis. For each 
cultivar taken into consideration, 5 different batches were available (each batch 
representing a different producer from the same geographical area): two samples 
from each batch were selected, the two halves of each sample were separated and 
three spectra in three different positions of each half were recorded. The average of 
each set of the three spectra was used for the statistical analysis, providing a total of 
60 spectra (3 cultivars x 5 batches x 2 samples x 2 halves). The halves were directly 
put on the ATR crystal without any further sample pre-treatment (18). 
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4.3.1.2 Instrumentation and software  
Fourier transform infrared spectral analysis of the hazelnut samples was carried out 
by ATR-FT-IR spectroscopy. All the spectra were recorded by an Agilent 4100 
Exoscan FTIR portable spectrometer (Agilent Technologies, Santa Clara, CA, USA). 
The spectra were obtained in absorption mode over a wavelength range from 650 
cm-1 to 4000 cm-1 at 32 scans per second, and a resolution of 4 cm-1. The total analysis 
time is about 15 seconds. Background readings were collected prior to each sample 
spectrum collection. The background was subsequently subtracted from each 
spectrum before data treatment.  
The spectra were processed by OPUS v.2.3 (Bruker Corporation, Billerica, MA, 
USA), statistical analysis and data pre-treatment were performed by The 
Unscrambler X 10.3 (Camo Inc., Oslo, Norway), Matlab 2014b (The MathWorks 
Inc., Natick, USA), Parvus (Prof Michele Forina, University of Genova, Italy) and 
the Classification Toolbox for Matlab from the Milano Chemometrics Group (38). 
Graphical representations were performed by Statistica v7.1 (Statsoft, Tulsa, OK, 
USA) (18). 
 
4.3.1.3 Spectra pre-treatment  
Each average spectrum was smoothed (moving average with step 3) to reduce the 
noise. Then, nine different pre-treatment algorithms were applied and compared: 
• Offset baseline; 
• Standard Normal Variate (SNV);  
• First Derivative (D1), calculated by the Sawitzky-Golay algorithm (second degree 
polynomial order; smoothing with 5 left and 5 right side points);  
• Second Derivative (D2), calculated by the Sawitzky-Golay algorithm (second 
degree polynomial order; smoothing with 5 left and 5 right side points); 
• Multiplicative Scatter Correction (MSC); 
• SNV followed by D1; 
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• MSC followed by D1; 
• SNV followed by D2; 
• MSC followed by D2. 
Each of the nine treatments just described was applied, independently, after the 
smoothing, and coupled to different classification methods to identify the strategy 
(spectra pre-treatment / classification tool) with the best predictive ability (18). 
 
4.3.1.4 Spectra pre-treatment theory 
Nine different spectra pre-treatment methods were applied. Here, the theoretical 
aspects of some of them are presented.  
Standard Normal Variate (SNV) is aimed to reduce baseline shifting or tilting due to 
non-specific scattering of radiation and variable spectral path length; this type of 
noise shows a larger effect at larger wavelengths. SNV correction is calculated, for 
each spectrum independently, by: 
𝑥′𝑖𝑗 =
𝑥𝑖𝑗−?̅?𝑖
𝑠𝑖
    (1) 
where xij is the absorbance measured at the j-th wavelength for the i-th sample, ?̅?𝑖 is 
the average absorbance of the original i-th spectrum and si in the standard deviation 
of the absorbance of the i-th spectrum. 
In Multiplicative Scatter Correction (MSC), the noise of each sample is estimated 
relatively to a reference sample, usually the average spectrum. MSC correction for 
each xij value is calculated as:  
𝑥′𝑖𝑗 =
𝑥𝑖𝑗−𝑎
𝑏
   (2) 
where xij is the intensity of the i-th spectrum and the j-th wavelength, while a and b 
are estimated for each sample by ordinary least-squares regression of spectrum xi 
versus the reference one (here, the average spectrum), over the available 
wavelengths.  
First Derivative (D1) and Second Derivative (D2) are usually applied with two 
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different purposes: to remove horizontal baselines of varying levels (D1) and of 
varying levels and slopes (D2) (74) (i.e. acting as filters); to operate a deconvolution 
of the spectra to identify adjacent and convoluted peaks (74). Here, deconvolution is 
the main objective since IR spectra presented a horizontal baseline.   
Combination of different pre-treatment procedures. SNV and MSC were combined 
with both D1 or D2 separately. As pointed out by Fearn (75,76), the order in which 
the two treatments (SNV or MSC and first or second derivative) are applied is 
relevant: here, after an initial smoothing procedure of each spectrum, D1 or D2 
followed the treatment by MSC or SNV (18). 
 
4.3.1.5 Classification models 
Each of the nine pre-treatment methods was coupled to the following three 
classification tools:  
• Principal Component Analysis followed by Linear Discriminant Analysis 
(PCA-LDA) carried out on the scores of the first 20 PCs calculated. The most 
discriminating PCs were selected by a variable selection procedure carried 
out by a stepwise algorithm in forward search, based on the best NER% in 
prediction. Cross-validation was accomplished by a leave-more-out 
procedure  with 10 cancellation groups: at each iteration of the cross-
validation procedure, one tenth of the samples was excluded from the 
calculation of the model and was used to evaluate its predictive ability. The 
samples taken out at each iteration were equally divided in the three classes.  
• Partial Least Squares – Discriminant Analysis (PLS-DA). The choice of the 
number of LVs to be retained in the final model was accomplished by cross-
validation with the same method adopted for PCA-LDA (the samples were 
divided in 10 cancellation groups) but in this case the procedure was repeated 
for 500 iterations randomly selecting at each iteration the samples included 
in each cancellation group. Once the number of LVs was identified, the 
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prediction ability of the final model was instead evaluated by cross-validation 
with a bootstrap procedure with 1000 iterations: at each iteration, 20% of the 
samples of each class was excluded from the training set and used to evaluate 
the predictive ability of the model. 
• Backward elimination PLS-DA (BE-PLS-DA). PLS-DA was applied with 
variable selection by a stepwise algorithm in backward elimination: at each 
iteration, a variable (i.e. wavenumber) is eliminated according to the 
minimum error obtained in cross-validation, selecting the variable to be 
excluded according to the smallest importance (19) calculated by leave-
more-out cross-validation with 10 cancellation groups. For each pre-
treatment method applied, a final model containing a different number of 
original variables (wavenumbers) was obtained. To guarantee both limited 
calculation times during the selection of the best number of LVs to be 
included in the models, and the reliable evaluation of the predictive ability of 
the final models, two different cross-validation procedures were applied: a) 
the number of LVs in the final models was identified by cross-validation with 
a random selection of the samples to be included in the model (10 
cancellation groups and 500 iterations); 2) the prediction ability of the final 
models was evaluated by cross-validation with a bootstrap procedure (1000 
iterations; 20% of the samples of each class excluded from the training set 
for each iteration) (18). 
The classification methods were applied to a restricted range of wavelengths 
containing only the significant signals, excluding wavelengths of the baseline. This 
led to the restricted range: 3660 – 2500 cm-1 and 1850-667 cm-1 (18). 
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4.3.2 Results and Discussion  
4.3.2.1 IR spectra of hazelnuts 
Figure 1 reports a sample spectrum recorded, showing the main bands as described 
in (61); the band assignments are reported in Table 1. 
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Figure 1: Example of a recorded spectrum (only the regions used for statistical analysis are 
represented). The overall spectrum is separated in three spectral regions to make the representation 
clearer. Vertical lines represent the wavenumbers identified as significant by BE-PLS-DA. The letters 
represent the band assignments as reported in Table 1. 
 
A simple visual inspection of the spectra was not able to point out clear differences 
due to the different cultivar. 
 
Table 1: Major bands assignments of hazelnuts IR spectra, as reported in (61). 
Spectral region Band assignment 
3050-3645 cm-1 O–H and N–H stretching due to polysaccharides and proteins (band A) 
2993-3020 cm-1 olefinic=CH stretching due to lipids (mainly unsaturated) (band B) 
2948-2967 cm-1 CH3 asymmetric stretching, due mainly to lipids with the little contribution 
from proteins, carbohydrates, nucleic acids (band C) 
2900-2940 cm-1 CH2 asymmetric stretching mainly due to lipids (mainly unsaturated) with the 
little contribution from proteins, carbohydrates, nucleic acids (band D) 
2829-2877 cm-1 CH2 symmetric stretching mainly due to lipids (mainly unsaturated) with the 
little contribution from proteins, carbohydrates, nucleic acids (band E) 
1714-1778 cm-1 ester C=O stretching due to triglycerides and phospholipids (band F) 
1599-1673 cm-1  amide I (protein C=O stretching) (band G) 
1510-1565 cm-1 amide II (protein N–H bending and C–N stretching) (band H) 
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1442-1479 cm-1 CH2 bending due to lipids and proteins (band I) 
 
Comparison of classification models 
Table 2 reports the results obtained for the three classification procedures in terms 
of accuracy, NER% and ER%, both in calibration and cross-validation.  
  Fitting Cross-validation   
  
A
c
c
u
ra
c
y
 
N
E
R
%
 
E
R
%
 
A
c
c
u
ra
c
y
 
N
E
R
%
 
E
R
%
 Number of PCs  
or LVs included  
in the model 
PCs or variables 
 included 
 in the final model* 
P
C
A
-L
D
A
 
Baseline 96.23 95.83 4.17 80.81 79.93 20.07 17 PCs 
PC7, PC2, PC3, PC13, PC4, PC8, 
PC17, PC5, PC1, PC20, PC11, PC14, 
PC10, PC19, PC12, PC18, PC9 
MSC 96.23 96.06 3.94 83.12 82.69 17.31 16 PCs 
PC15, PC2, PC17, PC3, PC11, PC6, 
PC4, PC13, PC16, PC1, PC5, PC10, 
PC8, PC7, PC18, PC9 
SNV 86.79 86.40 13.60 60.38 59.47 40.53 7 PCs 
PC4, PC12, PC15, PC11, PC2, PC17, 
PC19 
D1 100 100 0.00 88.23 88.02 11.98 15 PCs 
PC2, PC8, PC5, PC10, PC17, PC4, 
PC11, PC6, PC1, PC12, PC3, PC20, 
PC9, PC14, PC7 
D2 92.45 91.90 8.10 84.00 83.27 16.73 6 PCs PC5, PC1, PC2, PC4, PC6, PC8 
MSCD1 90.57 90.24 9.76 81.40 80.91 19.09 6 PCs PC4, PC10, PC9, PC18, PC2, PC15 
MSCD2 94.34 93.98 6.02 80.82 80.20 19.80 7 PCs PC6, PC3, PC4, PC1, PC7, PC5, PC20 
SNVD1 86.79 86.96 13.04 72.06 72.09 27.91 7 PCs 
PC4, PC2, PC1, PC18, PC20, PC15, 
PC13 
SNVD2 94.34 94.21 5.79 81.63 81.16 18.84 9 PCs 
PC6, PC3, PC4, PC1, PC18, PC20, 
PC19, PC12, PC5 
P
L
S
-D
A
 
Baseline 100 100 0 88.87 88.52 11.48 15 LVs  
MSC 100 100 0 86.74 86.44 13.56 14 LVs  
SNV 100 100 0 87.53 87.35 12.65 20 LVs  
D1 100 100 0 89.05 88.86 11.14 11 LVs  
D2 100 100 0 84.70 84.57 15.43 6 LVs  
MSCD1 100 100 0 87.92 87.62 12.38 15 LVs  
MSCD2 100 100 0 85.65 85.53 14.47 7 LVs  
SNVD1 100 100 0 88.86 88.64 11.36 13 LVs  
SNVD2 100 100 0 85.90 85.75 14.25 6 LVs  
B
E
-P
L
S
-D
A
 
Baseline 100 100 0 92.82 92.54 7.46 12 LVs 166 original variables 
MSC 100 100 0 91.49 91.36 8.64 13 LVs 188 original variables 
SNV 100 100 0 93.57 93.41 6.59 14 LVs 202 original variables 
D1 100 100 0 95.79 95.66 4.34 13 LVs 85 original variables 
D2 100 100 0 93.72 93.70 6.30 5 LVs 266 original variables 
MSCD1 100 100 0 95.81 95.77 4.23 10 LVs 130 original variables 
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MSCD2 100 100 0 98.00 97.81 2.19 4 LVs 90 original variables 
SNVD1 100 100 0 94.68 94.65 5.35 9 LVs 276 original variables 
SNVD2 100 100 0 98.18 98.06 1.94 3 LVs 102 original variables 
*For PCA-LDA, the last column reports the PCs in the order they are included  in the final model. For BE-PLS-DA, the last column 
reports the number of origina l variables retained as signification by the variable selection procedure. 
Table 2: Results of the application of the different classification methods: Accuracy, NER%, ER% in 
fitting and in cross-validation. Results in bold represent the best models obtained for each 
classification method.  
 
Table 3 reports instead the results obtained for what regards class overlapping and 
purity: precision, sensitivity and specificity, both in calibration and cross-validation. 
All the results are reported as percentages. Table 3 reports only the results obtained 
for all the data pre-treatments for each classification method separately.  
 
   Fitting Cross-validation 
   TGL Mortarella TGR TGL Mortarella TGR 
P
C
A
-L
D
A
 
Baseline 
Precision 90 100 100 70.54 78.05 95.47 
Sensitivity 100 87.5 100 86.88 63.55 89.35 
Specificity 94.29 100 100 81.34 92.39 97.6 
MSC 
Precision 100 93.75 95 80.01 81.55 87.63 
Sensitivity 94.44 93.75 100 89.09 73.01 85.97 
Specificity 100 97.3 97.06 88.62 92.86 93.17 
SNV 
Precision 81.82 85.71 94.12 59.78 53.92 65.08 
Sensitivity 100 75 84.21 67.4 42.98 68.03 
Specificity 88.57 94.59 97.06 76.06 84.5 79.67 
D1 
Precision 100 100 100 88.97 83.22 91.83 
Sensitivity 100 100 100 93.17 82.85 88.03 
Specificity 100 100 100 94.00 92.81 95.65 
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D2 
Precision 89.47 92.86 95 80.55 77.95 91.92 
Sensitivity 94.44 81.25 100 87.43 68.53 93.86 
Specificity 94.29 97.3 97.06 89.12 91.58 95.42 
MSCD1 
Precision 94.74 86.67 89.47 93.19 70.23 78.97 
Sensitivity 100 81.25 89.47 95.52 68.88 78.35 
Specificity 97.14 94.59 94.12 96.35 87.47 88.44 
MSCD2 
Precision 89.47 93.33 100 74.69 76.34 91.18 
Sensitivity 94.44 87.5 100 85.56 67.35 87.68 
Specificity 94.29 97.3 100 85.13 90.96 95.25 
SNVD1 
Precision 80.95 87.5 93.75 75.02 69.69 70.39 
Sensitivity 94.44 87.5 78.95 88.55 68.22 59.49 
Specificity 88.57 94.59 97.06 84.61 87.37 86.02 
SNVD2 
Precision 94.12 88.24 100 77.88 75.07 90.68 
Sensitivity 88.89 93.75 100 79.45 74.16 89.87 
Specificity 97.14 94.59 100 88.34 89.5 94.79 
P
L
S
-D
A
 
Baseline 
Precision 100 100 100 87.57 85.88 92.73 
Sensitivity 100 100 100 95.7 80.35 89.51 
Specificity 100 100 100 92.93 94.3 96.12 
MSC 
Precision 100 100 100 87.76 83.89 87.97 
Sensitivity 100 100 100 92.49 79.16 87.68 
Specificity 100 100 100 93.4 93.43 93.27 
SNV 
Precision 100 100 100 87.06 86.41 88.92 
Sensitivity 100 100 100 91.53 82.65 87.87 
Specificity 100 100 100 93.01 94.33 93.92 
D1 
Precision 100 100 100 89.35 82.69 94.52 
Sensitivity 100 100 100 91.18 84.74 90.67 
Specificity 100 100 100 94.37 92.3 97.1 
D2 
Precision 100 100 100 83.43 78.52 91.88 
Sensitivity 100 100 100 86.9 81.79 85.02 
Specificity 100 100 100 91.04 90.41 95.81 
MSCD1 
Precision 100 100 100 85.26 85.53 92.74 
Sensitivity 100 100 100 92.96 80.52 89.4 
Specificity 100 100 100 91.75 94.1 96.08 
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MSCD2 
Precision 100 100 100 86.20 79.29 91.01 
Sensitivity 100 100 100 89.86 81.76 84.97 
Specificity 100 100 100 92.66 90.69 95.31 
SNVD1 
Precision 100 100 100 86.79 86.63 92.9 
Sensitivity 100 100 100 92.72 82.99 90.21 
Specificity 100 100 100 92.78 94.4 96.17 
SNVD2 
Precision 100 100 100 85.91 80.31 90.87 
Sensitivity 100 100 100 90.38 81.11 85.74 
Specificity 100 100 100 92.52 91.42 95.08 
B
E
-P
L
S
-D
A
 
Baseline 
Precision 100 100 100 91.80 90.83 95.52 
Sensitivity 100 100 100 97.65 86.43 93.55 
Specificity 100 100 100 95.43 96.25 97.58 
MSC 
Precision 100 100 100 92.64 91.28 90.56 
Sensitivity 100 100 100 96.57 86.1 91.39 
Specificity 100 100 100 96.14 96.33 94.71 
SNV 
Precision 100 100 100 93.65 94.73 92.58 
Sensitivity 100 100 100 95.88 89.98 94.36 
Specificity 100 100 100 96.62 97.86 95.78 
D1 
Precision 100 100 100 94.31 93.06 99.48 
Sensitivity 100 100 100 95.35 93.92 97.7 
Specificity 100 100 100 97.04 97.06 99.71 
D2 
Precision 100 100 100 92.56 92.59 95.9 
Sensitivity 100 100 100 97.56 91.7 91.86 
Specificity 100 100 100 96.05 96.77 97.79 
MSCD1 
Precision 100 100 100 95.77 95.07 96.47 
Sensitivity 100 100 100 98.44 94.32 94.55 
Specificity 100 100 100 97.75 97.89 98.07 
MSCD2 
Precision 100 100 100 96.69 99.45 98.15 
Sensitivity 100 100 100 99.80 93.97 99.64 
Specificity 100 100 100 98.25 99.78 98.93 
SNVD1 
Precision 100 100 100 92.26 94.81 97.13 
Sensitivity 100 100 100 97.18 93.46 93.33 
Specificity 100 100 100 95.77 97.77 98.48 
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SNVD2 
Precision 100 100 100 97.02 98.65 98.91 
Sensitivity 100 100 100 98.92 95.78 99.48 
Specificity 100 100 100 98.43 99.44 99.39 
Table 3: Results of the application of the different classification methods: Precision, Sensitivity, 
Specificity in fitting and in cross-validation. 
For what regards PCA-LDA, the best results are obtained by calculating the first 
derivative of each spectrum: the final model contains 15 PCs (the order in which they 
are included in the model is reported in table 2) and guarantees the perfect 
classification of all the samples in calibration, but the accuracy decreases to about 
88% in cross-validation. With D1 treatment, specificity is always greater than 92% 
for the three classes, while sensitivity shows values larger than 90% only for the first 
class and precision shows values larger than 90% only for the third class. The number 
of PCs included in the model is quite large; this is due in part to the applied method: 
since in PCA-LDA, LDA is applied to PCs, i.e. directions of maximum variance 
calculated in an unsupervised manner, the number of PCs to achieve good 
classification performances can be rather large if class belonging is not the only 
source of relevant information. Moreover, here, the natural variability of the hazelnut 
products needed a larger number of PCs to be taken into account properly. It must 
be pointed out that in this approach no selection of the original variables was 
operated: the overall spectrum was used to describe each sample, thus including also 
wavenumbers not directly related to classification, increasing the experimental error. 
The large number of PCs included reflects also in the not very good accuracy 
obtained in cross-validation: PCA-LDA provides good results but samples appear 
not very well separated in the three classes.  
Similar results are obtained by PLS-DA where the best model performances are 
obtained after D1 treatment and the final model includes 11 LVs showing the perfect 
classification of all the samples in calibration, but an accuracy of about 89% in cross-
validation. With D1 treatment, specificity is always greater than 92% for the three 
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classes, while sensitivity shows values larger than 90% for the first and third classes 
and precision shows values larger than 90% only for the third class. The number of 
LVs included in the model is large but smaller than the number of PCs in PCA-LDA: 
this is due to the fact that LVs are calculated in a supervised manner, usually 
providing a simpler model; however, the number of LVs is yet large due to both the 
natural variability of hazelnuts and the fact that no variable selection was applied, 
including therefore in the final model also wavenumbers not directly related to 
classification.  
The best overall results are obtained by PLS-DA with variable selection: the best 
model performances are obtained in this case after a D2 treatment coupled to both 
MSC or SNV (in this last case the model is slightly better). The final model 
(SNV+D2) contains only three LVs and is calculated on 102 original variables (for 
a better description of the 102 variables identified as discriminating, refer to 
paragraph 4.3). This model allows the perfect classification of all the samples in 
calibration, while the accuracy is of about 98% in cross-validation. Specificity is 
always greater than 98% for all the classes, while sensitivity is always greater than 
95% and precision is always greater than 97%. This model is really satisfactory for 
the purpose of discriminating the 3 types of samples. In this case, only 3 LVs are 
included in the final model and very good classification performances are obtained. 
This is mostly due to the variable selection procedure, able to eliminate from the 
model the original variables not related to classification and reduce therefore the 
experimental error accounted for by the final model. The number of retained 
variables accounts for this effect: out of the 629 original wavenumbers, just 102 were 
retained in the final model. This was selected as the best overall model both due to 
its very good classification performances and to its simplicity in terms of number of 
original variables/LVs included in the final model (18). 
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PLS-DA with variable selection 
The best results were obtained by PLS-DA coupled to variable selection, after pre-
treatment by SNV and D2. Figure 2 reports the score plot of the first three latent 
variables: the samples appear well grouped according to the different cultivars. The 
first LV mainly separates the TGL samples (at positive values) from the TGR 
samples (at negative values), while the second LV mainly separates Mortarella (at 
positive values) from the other two classes (at negative values).  
 
Figure 2: BE-PLS-DA results: score plot of the first three LVs calculated (the score plot represents 
the samples indicated with different markers according to the three different classes). 
 
Figure 3a-c reports instead the regression coefficients of the three classes, calculated 
on the basis of the first three LVs: for each class, positive regression coefficients 
indicate wavelengths that have a large signal for the corresponding class, while 
negative coefficients indicate regions with a small signal in the corresponding class. 
It must be pointed out however that the spectra were treated by SNV followed by the 
second derivative, therefore the discussion about the behavior of the different 
148 
 
spectral bands according to the different cultivars must take it into account. For a 
clearer interpretation, a sample spectrum is represented in figure 1; the figure reports 
as vertical lines the wavenumbers that were selected as significant by BE-PLS-DA. 
As it can be noticed by the joint analysis of figure 3 and figure 1, the large band 
centered at about 3340 cm-1 (band A) shows a great influence on the cultivar: this 
band represents the convolution of signals involving the N-H stretching of Amide A 
of proteins, with contributions from the O-H stretching from inter- and intra- 
molecular hydrogen bonds (34). The complex convolution of these modes reflects in 
the complex behavior of the second derivative that shows some regions within this 
band where the signal can discriminate between TGR and TGL samples (mainly at 
larger wavenumbers; larger signals for TGR and smaller for TGL) and other regions 
that discriminate between Mortarella and the other two classes (mainly at smaller 
wavenumbers within this band).   
The band at 2959 cm-1 corresponds to the asymmetric stretching of CH3 groups and 
is mainly related to lipids, that show a larger signal in TGL samples than in 
Mortarella.   
The band at 1650 cm-1 corresponds to the amide I vibrations of structural proteins: 
this band shows a larger signal in TGL samples and a smaller signal in TGR samples. 
For what regards the other signals identified as significant in the discrimination 
between the classes, they all belong to regions were a relevant absorption is recorded 
for the samples, however, these signals correspond in general to shoulders of the 
major bands, pointing out that the differences between the three investigated 
cultivars are quite slight and do not reside in major absorbment peaks (18). 
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Figure 3: BE-PLS-DA results: regression coefficients of the 102 significant original variables 
separately for the three classes considered (a-c). 
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4.3.3 Conclusions  
FTIR spectroscopy was applied for the identification of the cultivar of raw hazelnuts. 
The infrared spectra collected on the raw hazelnuts from three cultivars (TGL, 
Mortarella and TGR), were processed by different pre-treatment algorithms coupled 
to three different classification methods (PCA-LDA, PLS-DA and BE-PLS-DA). 
The best classification performances were obtained by BE-PLS-DA after spectra pre-
treatment by SNV, followed by the calculation of the second derivative. The final 
model includes 102 original wavelengths and provides the perfect classification of 
all the samples in calibration as well as very good performances in cross-validation. 
The applied cross-validation procedure (bootstrap with 1000 iterations; 20% of the 
samples of each class excluded from the training set for each iteration) allowed to 
obtain a robust evaluation of the prediction ability of the models notwithstanding the 
lack of a test set for an external prediction.  
The analysis of the significant wavelenghts pointed out that differences among the 
cultivars reside in some major contributions, mainly due to lipids (for discriminating 
TGL from Mortarella) and proteins (for discriminating TGL from TGR). However, 
the good classification performances are also due to other signals that regard 
shoulders of the major bands.  
The model built provides an important proof of concept of the ability of ATR-FT-IR 
spectroscopy coupled to multivariate statistical methods for the identification of the 
cultivar of raw hazelnuts. This application is of particular interest since hazelnuts 
from different origins are characterized by very different commercial values, with 
“Tonda Gentile delle Langhe” representing the product more suitable for 
confectionery. The applied methodology represents an important advance in the field 
of cultivar identification of raw hazelnuts for the food industry, showing high 
sensitivity, simplicity and above all not requiring any particular sample preparation; 
the analysis is very fast (about 30 seconds per sample, including the sample 
treatment); to the advantages of FT-IR spectroscopy, the possibility of on-site 
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measurements is an important added value, making this application particularly 
effective for industrial quality control.  
To this purpose, in spite of seeming a quite complex data treatment, for a future 
application in on-line industrial quality controls, SNV and D2 calculation can be 
accomplished automatically in a few fractions of seconds by standard software 
packages or by home-made algorithms developed in Matlab or R environments. For 
what regards the variable selection procedure by BE-PLS-DA, once the model is 
calculated on the samples of the training set, the coefficients calculated for each 
selected original variable can be used to calculate the class belonging of any new 
sample in a very fast way. The application represents therefore an important proof 
of concept of the applicability of this approach in industrial quality control (18). 
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5 CHAPTER 5 
 
 
5.1   Conclusions 
The studies carried out within this PhD thesis project allowed to highlight the 
importance of elemental profiling, coupled to multivariate statistical tools, as an 
analytical approach to face modern problems in the field of applied and life 
sciences from two different points of view: the use of elemental profiling to 
evaluate the variation of heavy metals concentrations in urine samples during a 
chelation therapy; the use of the same profiling technique for food authentication, 
to promote the value of food products.   
The first part of this Ph.D. thesis was therefore focused to study the effectiveness 
of chelating therapy and deepen the knowledge about what cations may or may not 
be excreted during the therapy, exploiting a patient diagnosed with chronic fatigue 
syndrome as case study.  Urine samples were systematically collected before and 
after the chelation therapy and the results confirmed the efficacy of the therapy in 
the elimination of the heavy metals accumulated in the body. In fact, several 
elements showed an excretion peak in the 12 hours after the EDTA administration, 
while for others the elimination continued for 36 hours after the treatment, showing 
a pattern defined as “basal excretion”. It was interesting to note the large excretion 
of Rb and Ti, whose toxic effects have been scarcely investigated. Therefore, it is 
worth to further investigate, in order to clarify the origin of their presence in the 
patient’s body and their potential patho-physiological effects. Since it resulted that 
also beneficial microelements are massively eliminated, I confirmed that it is 
mandatory to introduce adequate dietary supplements in the time interval between 
two EDTA administrations. 
The  mechanisms of action of the chelation therapy were further investigated by a 
proteomic approach, monitoring the effects and pathways involved during the 
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chelating therapy, through shotgun proteomics of plasma samples, before and after 
the chelating therapy. Our results showed a significant modulation of the proteins 
related to redox balance in cells and to the elimination of ROS in plasma. 
Moreover, for the first time, we shed light on the mechanism of how chelation can 
reduce major cardiovascular events. In fact, although the effect of EDTA on 
cardiovascular diseases has already been studied by several projects and 
consortiums, its effect on the broad plasma proteome was never considered. The 
results obtained with the shotgun proteomic approach allowed us to identify the 
down regulation of proteins related to lipoprotein processes (i.e. APOC3, APOC2 
and RET4), which are associated to high cardiovascular risk.  
The purpose of the second part of the PhD study was instead to define a system to 
ensure the authentication of food products by exploiting rare earth (REEs) and 
other elements as indicators. These analytes were determined by ICP-MS and ICP-
OES, using hazelnuts as the case study. This study involving the production chain 
of hazelnut paste: from raw fruits, to roasted hazelnuts, down to the final paste of 
three different hazelnut cultivars (“Tonda Gentile delle Langhe, TGL”, “Romana, 
TGR” and “Mortarella”). PLS-DA with variable selection was applied to identify a 
model able to distinguish the three cultivars, independently on the type of 
technological transformation, and to search for elemental markers of authenticity. 
The model performances were very good both in fitting and cross-validation with 
accuracy always greater than 96.9%.  
The results obtained show that authentication of hazelnuts along the production 
chain of hazelnuts paste, passing from raw to roasted fruits and then producing the 
corresponding paste, is possible with a good accuracy, based on the elemental 
profiling of both major elements and trace and ultra-trace elements. To the authors 
knowledge, this is the first authentication study involving the production chain of 
this product.  
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Authentication of hazelnuts was also carried out by a parallel approach exploiting 
FTIR spectroscopy using a  portable FTIR spectrometer.  
The multivariate classification methods, namely principal component analysis 
(PCA) followed by linear discriminant analysis (LDA) and partial least square 
discriminant analysis (PLS-DA), with or without variable selection, were applied to 
process the infrared spectra collected on the raw hazelnuts from three cultivars 
(TGL, TGR and Mortarella). 
These methods allowed a very good discrimination among the groups, with PLS-
DA coupled to variable selection providing the best results. The analysis showed 
that the differences between the cultivars reside in some important contributions, 
mainly due to lipids (to discriminate Mortarella's TGL) and proteins (to 
discriminate TGL of TGR). 
The applied methodology represents an important advance in the field of cultivar 
identification of raw hazelnuts for the food industry, showing high sensitivity, 
simplicity, the possibility of on-site measurements  and above all not requiring any 
particular sample preparation and the analysis is very fast (about 30 s per sample, 
including the sample treatment).  
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